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Fusarium spp are common contaminants of maize and produce many mycotoxins, including the 
fusariotoxin fusaric acid (FA).  FA is a niacin related compound, chelator of divalent cations, 
and mediates toxicity via oxidative stress and possible mitochondrial dysregulation. Sirtuin 3 
(SIRT3) is a stress response deacetylase that maintains proper mitochondrial function. The 
effect of FA on SIRT3 and oxidative and mitochondrial stress pathways in the hepatocellular 
carcinoma (HepG2) cell line were investigated. We determined FA toxicity (24h incubation;     
IC50= 104µg/ml) on mitochondrial output, cellular and mitochondrial stress responses, 
mitochondrial biogenesis and markers of cell death using spectrophotometry, luminometry, 
qPCR and western blots. FA caused a dose dependent decrease in metabolic activity along with 
significant depletion of intracellular ATP (p = 0.0062). FA induced a significant increase in 
lipid peroxidation (p = 0.0002), despite up-regulation of the anti-oxidant transcription factor, 
Nrf2 (p < 0.0014). FA significantly decreased expression of SIRT3 mRNA (p = 0.0007) with a 
concomitant decrease in protein expression (p = 0.0012). Lon protease was also significantly 
down-regulated (p = 0.0044). FA induced aberrant mitochondrial biogenesis as evidenced by 
significantly decreased protein expressions of: PGC-1α (p = 0.0005), p-CREB (p = 0.0008), 
NRF1 (p = 0.0004) and HSP70 (p = 0.0102). Finally, FA activated apoptosis as noted by the 
significantly increased activity of caspases 3/7 (p = 0.0032) and also induced cellular necrosis 
(p<0.0001). This study provides insight into the molecular mechanisms of FA (a neglected 
mycotoxin) induced hepatotoxicity and may aid in understanding and predicting the 
contamination risks of FA. This is of particular importance to developing countries where the 








Third world countries, particularly those found in Africa are faced with a multitude of socio-
economic struggles making it one of the most food insecure regions. The Food and Agriculture 
Organization (FAO) defines food security as “a situation that exists when all people, at all 
times, have physical, social, and economic access to sufficient, safe, and nutritious food to meet 
their dietary needs and food preferences for an active and healthy life” (Schmidhuber and 
Tubiello, 2007).  But in Africa, the challenge to meeting the above mentioned criteria are 
hampered by an ever increasing population and intense poverty often leading to the 
consumption of contaminated food.  
Maize is an important food source for millions of South Africans (Boutigny et al., 2011). Fungi 
under suitable conditions parasitize agricultural produce including maize. These fungi produce 
secondary metabolites known as mycotoxins that benefit the fungi by being toxic to other 
organisms thereby acting as a survival mechanism (Hussein and Brasel, 2001). Maize is infected 
by a number of fungal pathogens including members of the genera Fusarium. The growing 
interest in Fusarium species stems from their ability to produce fusariotoxins (Nedělník, 2002).  
Acute and chronic effects are implicated in diseased states (Coulombe, 1993) and is dependent 
on the species and susceptibility of the animal to the toxin (Pal et al., 2015).  Acute toxicity 
results in a rapid onset of toxin induced responses while chronic exposure is characterized by 
low levels of toxin over a long time period often resulting in irreversible damage and 
carcinogenesis (Pal et al., 2015). An often neglected fusariotoxin is fusaric acid (FA), a niacin 
(i.e. nicotinamide) related compound (Ogata et al., 2001) and efficient chelator of divalent 
cations (Hirai et al., 2005, Stack et al., 2004).  
Fusaric acid (5-butylpicolinic acid) is a derivative of picolinic acid and is produced mainly by 
Fusarium moniliforme (Nedělník, 2002), it possesses only low to moderate toxicity and has 
several pharmacological properties evident in the cardiovascular, immune and nervous systems 
(Stack et al., 2004, Wang and Ng, 1999). FA enhances the toxicity of other mycotoxins and this 
synergism is considered the major contributor to its mechanism of action (Malovrh and 
Jakovac-Strajn, 2010, Fairchild et al., 2005). These synergistic effects can be attributed to the 
presence of a plethora of Fusarium spp. and strains within the contaminated feed samples or due 
to multiple mycotoxins being produced by the same species (Bacon et al., 1996). Regardless, an 
analysis focusing on a single toxin is likely to show better correlation between its concentration 
xix 
 
and induced toxicity. Mycotoxins exert a variety of biological effects owing to their diverse 
chemical structures, thus no generalized mechanism of action can be applied to all mycotoxins 
(Kiessling, 1986).  
Several studies on FA showed it to induce oxidative stress by down regulating anti-oxidant 
enzymes and increasing the production of reactive oxygen species (ROS) (Iwahashi et al., 1999, 
Jiao et al., 2014, Singh and Upadhyay, 2014). Excess ROS induces oxidative modifications to 
macromolecules, inhibits protein functions, promotes cell death (Circu and Aw, 2010) and has 
been implicated in disease initiation and progression (Qiu et al., 2010). Although ROS can be 
generated in many cellular compartments, the mitochondria is the major contributor (Balaban et 
al., 2005). ROS formation occurs when unpaired electrons escape the electron transport chain 
(ETC) and react with molecular oxygen (St-Pierre et al., 2006). FA may exert its toxic effects 
through dysregulation of mitochondrial processes (Telles-Pupulin et al., 1998) leading to excess 
ROS generation.   
Sirtuin 3 (SIRT3) is an important regulator of mitochondrial lysine acetylation (Lombard et al., 
2007). SIRT3 deacetylase activity is stimulated by its co-factor, nicotinamide adenine 
dinucleotide (NAD+) and inhibited by its reaction product, nicotinamide (NAM) (Guan et al., 
2014). SIRT3 influences homeostasis by targeting enzymes that regulate key mitochondrial 
processes including the Kreb‟s cycle (Finley et al., 2011) and oxidative phosphorylation 
(OXPHOS) (Ahn et al., 2008). SIRT3 also maintains mitochondrial integrity by regulating the 
stress response protein LON protease (LON) at the post-translational level (Gibellini et al., 
2014a). LON is an ATP dependent protease that catalyzes the degradation of oxidatively 
damaged proteins in the mitochondrial matrix. LON can also act as a chaperone protein, 
independent of its proteolytic activity and promotes the assembly of ETC subunits (Bota et al., 
2005 ).  
The primary defense against oxidative stress are endogenous anti-oxidant enzymes that 
scavenge excess ROS. The transcriptional co-activator, peroxisome proliferator-activated 
receptor gamma co-activator α (PGC-1α) interacts with various transcription factors to regulate 
biological programs (Lin et al., 2005). PGC-1α regulates ROS metabolism by mediating the 
expression of anti-oxidant enzymes catalase and superoxide dismutase (SOD) (St-Pierre et al., 
2006). Oxidative stress increases the expression of both PGC-1α, and SIRT3 expression through 
activation of estrogen-related receptor α (ERR-α) In turn, SIRT3 stimulates PGC-1α expression 
via phosphorylated cAMP response element binding protein (pCREB), thereby forming a 
positive feedback loop and increasing anti-oxidant defences (Kong et al., 2010). SIRT3 is also 
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known to enhance SOD2 activity (the primary mitochondrial superoxide detoxification enzyme) 
by deacetylation (Tao et al., 2010, Qiu et al., 2010).  
The induction of the transcription factor nuclear factor-erythroid 2-related factor (Nrf2) and 
subsequent mediation of phase 2 response is an important cellular reaction to oxidative stress 
and is dependent on the release of Nrf2 from its repressor Kelch-like ECH-associated protein 1 
(Keap1), a zinc thiol protein (Dinkova-Kostova et al., 2005). It has been suggested that Nrf2 is a 
transcriptional regulator of SIRT3 (Flick and Lüscher, 2012) and LON (Ngo et al., 2013 ). 
Mitochondrial biogenesis is a mechanism developed by cells to prevent mitochondrial lesions 
and maintain mitochondrial integrity (Esposti et al., 2012). PGC-1α is the master regulator of 
mitochondrial biogenesis and respiration (St-Pierre et al., 2006) by mediating the activity of 
several transcription factors including the transcription factor nuclear respiratory factor 1 (NRF-
1) (Yoboue and Devin, 2012). Furthermore, SIRT3 was shown to mediate the effects of PGC-1α 
on mitochondrial biogenesis (Kong et al., 2010). 
The liver is constantly being challenged by various stimuli making it a frequent site for damage 
from toxic insults. Toxins reach the liver in concentrated forms since ingested materials are first 
processed by the liver before entering systemic circulation. Furthermore, most detoxification 
reactions are carried out mainly by the liver ameliorating toxicity  (Fenton, 2002). Furthermore, 
the high density of mitochondria within liver cells is key to cell survival, with even mild 
mitochondrial dysfunction resulting in oxidative stress and cell death. The liver derived HepG2 
cell line is widely used as an in vitro toxicity model that reflects xenobiotic metabolism owing 
to inducible expression of detoxification enzymes (Mersch-Sundermann et al., 2004).  
Although a common contaminant of agricultural produce little is known about the underlying 
molecular mechanisms of FA induced oxidative stress and mitochondrial dysfunction. We 
investigated the effects of the niacin related compound, FA, on SIRT3 and its ability to induce 
oxidative and mitochondrial stress in the HepG2 liver cell line.  
1.2.  Problem statement  
Maize is the staple diet of majority population in South Africa and is also used as feed for live-
stock. This puts the public at risk of exposure to mycotoxins in particular those produced by the 
Fusarium spp. (ubiquitous soil fungi).  Many studies have been carried out on various 
fusariotoxins, but to date, little work has been done on FA. Although chelation and induction of 
oxidative stress have been cited as general mechanisms of FA toxicity, molecular pathways 




The aim of this study was to investigate the mechanism of FA cytotoxicity and mitochondrial 
toxicity in the HepG2 liver cell line.  
1.4. Research questions  
This study focused specifically on the cytotoxic and mitochondrial toxic effects of FA in a liver 
cell line. The liver is the main site of xenobiotic metabolism and is densely populated with 
mitochondria making it prone to toxic insult by FA. The following research questions were 
posed:  
 Does FA interfere with liver cell metabolism and mitochondrial output? 
 Does FA induce liver cell mitochondrial stress? 
 Does FA affect liver cell mitochondrial biogenesis? 
1.5. Objectives  
 Determine metabolic activity of liver cells treated with FA 
 Determine molecular mechanisms involved in the dysregulation of mitochondrial stress 
responses in liver cells treated with FA 
1.6. Hypothesis  
It was hypothesised that FA (a weak acid) induced mitochondrial toxicity in HepG2 cells by 
mediating dysregulation of key proteins involved in mitochondrial function and stress 
responses.  
1.7.  Experimental approach  
The human HepG2 hepatocellular carcinoma cell line was used as a model to investigate the 
mitochondrial toxic properties of FA. Cells were treated for 24 hours (h) with a range of FA 
concentrations to determine cell viability and the concentration that yielded a 50% reduction in 
viability (IC50; deduced from the dose-response curve). All assays to determine mitochondrial 
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Figure 1: A schematic showing the experimental approach followed to investigate the 
effects of  FA in cultured HepG2 liver cells; Adenosine triphosphate (ATP),  Heat shock 
protein 70 (HSP70), Lactate dehydrogenase (LDH), Metyhyl thiazol tetrazolium (MTT),  
Nuclear factor-erythroid 2-related factor 2 (Nrf2),  Nuclear respiratory factor 1(NRF-1), 
Peroxisome proliferator-activated receptor gamma co-activator 1α (PGC-1),  
phosphorylated Cyclic AMP response binding element protein (pCREB),  Quantitative 
polymerase chain reaction (qPCR),  Single cell gel electrophoresis (SCGE), Thiobarbituric 




CHAPTER 1: LITERATURE REVIEW 
1.1. Mycotoxins  
1.1.1. Characteristics  
Mycotoxins are mould secondary metabolites produced when these fungi contaminate food and 
feed. One species of mould can produce a plethora of mycotoxins and the same mycotoxin can 
be produced by a variety of mould species. The severity of contamination is dependent on 
environmental factors as well as storage methods with humid conditions accelerating the rate of 
contamination (Coulombe, 1993). Ingestion of mycotoxins at various steps of the food chain 
(Zain, 2011) leads to an array of toxicity  in both animals and humans.  
Acute and chronic effects are implicated in diseased states (Coulombe, 1993) and is dependent 
on the species and susceptibility of the animal to the toxin (Pal et al., 2015).  Acute toxicity 
results in a rapid onset of toxin induced responses while chronic exposure is characterized by 
low levels of toxin over a long period of time often resulting in irreversible damage and 
carcinogenesis. Exposure to mycotoxins is mainly through ingestion of contaminated 
agricultural produce or consuming animal products containing mycotoxin metabolites, however, 
inhalation of fungal spores and dermal contact have also been cited as possible exposure routes 
(Zain, 2011, Pal et al., 2015).  
Secondary metabolites are structurally diverse, low molecular weight compounds with obscure 
functions, and unlike primary metabolites, which are universally distributed compounds of 
intermediary metabolism (Zain et al., 2013), secondary metabolites  are not  directly required to 
facilitate growth of the producing organism (Fox and Howlett, 2008). Regulation of secondary 
metabolism in fungi is complex, responding to environmental cues and host stimuli (Fox and 
Howlett, 2008). Most secondary metabolites are synthesized from a few precursors which 
branch from a limited number of primary metabolism reaction points (Zain et al., 2013). 
Secondary metabolites play roles in reproduction and differentiation and are often associated 
with providing the producing organism with a competitive advantage allowing them to survive 
in their ecological niche (Fox and Howlett, 2008) through inhibiting the growth of other 




1.1.2. Biological effects of mycotoxins  
While all mycotoxins are fungal in origin, not all toxic compounds produced are termed 
mycotoxins. The cellular target and concentration of the metabolite are both important (Zain, 
2011). Mycotoxicoses presents with symptoms resulting from the interactions of functional 
molecules and organelles with mycotoxins. Mycotoxins exert a variety of biological effects 
owing to their diverse chemical structures, thus no generalized mechanism of action can be 
applied to all mycotoxins (Kiessling, 1986). 
Mycotoxins exert their biological effects by altering basic cellular processes including 
mitochondrial function, carbohydrate metabolism, lipid and steroid metabolism as well as the 
biosynthesis of protein and DNA (Figure 1.1). A mycotoxin may act primarily on the DNA 
template, or impair and inhibit transcription and translation processes thus interfering with 
protein synthesis. These primary events may then result in secondary effects in which metabolic 
processes are altered due to aberrant enzyme activity and regulation (Kiessling, 1986).   
Many mycotoxins act at the level of DNA and RNA processing with several showing 
carcinogenic potential. Strong correlations can be established between carcinogenicity and the 
extent of covalent DNA binding among mycotoxins such as aflatoxin B1 and its related 
compounds. These covalent bonds often cause mutations leading to cancer. Mycotoxins are able 
to inhibit DNA synthesis and induce both single and double strand breaks. The inhibition of 
RNA polymerase and decrease in RNA content  by mycotoxins (Kiessling, 1986) show that 
these metabolites are able to affect transcriptional processes.  
Inhibitory effects of mycotoxins on transcriptional and translational processes, including those 
of the mitochondria  (Bin-Umer et al., 2011) may result in the inhibition of protein synthesis 
and enzyme activity resulting in modified cellular processes and metabolism. A vast array of 
mycotoxins has been shown to adversely affect mitochondria. This is achieved through the 
inhibition of the Kreb‟s cycle, uncoupling of oxidative phosphorylation and through competitive 
inhibition of mitochondrial transport proteins (Kiessling, 1986). Furthermore mycotoxins were 
shown to increase reactive oxygen species (ROS) generation and decrease mitochondrial 
membrane potential (Bin-Umer et al., 2011).  
Numerous mycotoxins are implicated in the dysregulation of lipid metabolism, aflatoxin B1 is 





At the organ level, mycotoxins have been shown to stimulate immune activity but inhibit 
immune cell proliferation resulting in an incompetent immune response. Mycotoxins are also 
known to cause constriction of the small airways. But the most threatening effect of mycotoxin 
exposure is the risk of carcinogenesis and mutagenesis, particularly in metabolizing organs such 


















Figure 1.1: Mycotoxins exert a variety of biological activities and inhibit various cellular 





1.2.1. Liver functions and structure  
The liver serves a multitude of functions and plays key roles in metabolism, secretion, excretion 
and immune responses. The major metabolic and synthetic functions of the liver include 
carbohydrate, lipid and protein metabolism. Synthesis of proteins, mainly albumin takes place in 
the liver as well as the excretion of exogenous compounds such as xenobiotics and endogenous 
substances like bilirubin. The liver also secretes bile which is needed for the absorption of fat 
and fat soluble vitamins in the small intestine (Mitra and Metcalf, 2009). The immunological 
functions of the liver are executed by hepatic macrophages known as Kupffer cells (Fenton, 
2002).   
The liver is composed of highly metabolic cells. Liver cells are called hepatocytes and are 
organized in rows forming lobules (Campbell, 2006) adjacent to sinusoids. Sinusoids are spaces 
that are supplied by branches of the hepatic artery and portal vein which in turn supply 
hepatocytes with solutes from blood (Figure 1.2). These solutes bathe the hepatocytes which 










Figure 1.2: Basic structure of the liver (prepared by author). 
Hepatocytes are rich in smooth and rough endoplasmic reticulum which is necessary to carry 
out xenobiotic metabolism and protein synthesis respectively (Campbell, 2006). The liver also 
possesses a high number and density of mitochondria which form an integrative hub of 
carbohydrate, lipid and protein metabolism as well as being essential regulators of hepatocyte 




production the latter being needed for cellular signaling, fine tuning responses to stress and 
global adaptations to metabolism (Esposti et al., 2012).   
The liver is the primary site of xenobiotic metabolism. Most compounds are not intrinsically 
toxic to the liver and require metabolic transformation into a toxic metabolite via a process 
known as bioactivation. Since gastrointestinal absorption is enhanced by lipophilicity of a 
compound the liver is essential to the conversion of these compounds to more water soluble 
metabolites that can be excreted (Sturgill and Lambert, 1997). There are two types of reactions 
involved in xenobiotic metabolism: phase I and phase II reactions. Phase I reactions occur first 
and involve oxidation, hydrolysis or reduction of the xenobiotic and enhance water solubility by 
generating hydroxyl, carboxyl, or epoxide functional groups on the parent compound. These 
functional groups can then facilitate phase II reactions which further enhance water solubility 
through conjugation with glucuronate, sulphate or other glutathione moieties (Sturgill and 
Lambert, 1997). 
1.2.2. Hepatotoxicity  
The severity of xenobiotic toxicity is largely determined by the organisms‟ rate of metabolism 
(Swick, 1984). Toxic chemicals frequently damage the liver as the portal vein carries ingested 
material directly to the liver in a relatively concentrated form. Furthermore toxins are 
concentrated in the liver since most detoxification reactions occur in this organ, included 
amongst these reactions is bioactivation in which the pre-toxin is converted to a toxic form by 
metabolic enzymes (Fenton, 2002). Injury to hepatocytes can be cytotoxic (morphological 
changes to cells), genotoxic (damage to DNA) or metabolic (affecting cell metabolism and 
mitochondria)  (Figure 1.3) (Castell et al., 1997); and is dependent on the toxin as well as the 
degree and frequency of exposure. All of these factors contribute to hepatotoxicity and 
culminate in aberrant cell survival processes leading to necrotic hepatocyte death or 
carcinogenesis (Fenton, 2002). 
Hepatocellular carcinoma (HCC) is the primary malignancy of the liver (Zhao et al., 2011) and 
is the fifth most common cancer worldwide. It is a growing malignancy with poor patient 
survival despite the development of new treatments over the past few decades (Bodzin and 
Busuttil, 2015).  
The epidemiology of HCC is complex and involves a host of factors and co-factors. Chronic 
infection with the hepatitis B virus and hepatitis C virus (HBV and HBC respectively) are 
responsible for the majority of cases of HCC cases worldwide. Of concern, particularly in 




aflatoxin. The synergism between HBV and aflatoxin exposure increases the risk of developing 
HCC. Human immunodeficiency virus (HIV) infection is also thought to increase rates of HCC 
in HBV-infected individuals and this may be of particular relevance in sub-Saharan Africa, 
where 67% of all individuals living with HIV reside (Venook et al., 2010, Kew, 2010 ).  
1.2.3. Use of the HepG2 cell line  
The liver derived HepG2 cell line is widely used as an in vitro toxicity model that reflects 
xenobiotic metabolism owing to inducible expression of phase I and phase II enzymes as well as 
the expression of anti-oxidant systems (Mersch-Sundermann et al., 2004). This suggests that the 











Figure 1.3: Mechanisms of hepatotoxicity (prepared by author).  
1.3. Picolinic acid  
Picolinic acid (PA) is a six-membered ring structure compound (pyridine ring), containing five 
carbon atoms, a nitrogen and a carboxyl group at position two (Grant et al., 2009) and is a 
niacin related compound (Ogata et al., 2000). Picolinic acid is primarily formed in the liver, 
kidney and brain (Grant et al., 2009) and is synthesized in a side pathway of NAD biosynthesis 
in animals (Ogata et al., 2001). Tryptophan can be metabolized via the kyneurinine pathway 
which oxidatively degrades this amino acid to yield kynurenic acid (KYNA), PA and NAD 
(Figure 1.4) (Grant et al., 2009). Picolinic acid is also produced as a toxin by the mould species 





















Figure 1.4: In vivo synthesis of PA via the kyneurine pathway (Grant et al., 2009) 
1.3.2. Mechanism of action  
The best characterised physical property of PA is its ability to efficiently chelate divalent metal 
cations including iron, zinc, copper, nickel and lead (Fernandez-Pol et al., 1977). Picolinic acid 
is related to niacin (i.e. nicotinic acid, nicotinamide) (Figure 1.5) which is a water soluble 
vitamin (Ogata et al., 2001) and plays various physiological roles in organisms (Ogata et al., 
2000). It can be converted to NAD in vivo. NAD is an important co-factor required for DNA 














Figure 1.5: Chemical structures of the isomers Picolinic acid (A) and Nicotinic acid (B)                                    
(Grant et al., 2009).  
1.3.3. Pharmacology 
Exploiting its chelatory capabilities, PA-metal complexes are now used as a means to introduce 
bioactive metals into biological systems. Chromium-picolinate supplementation has been 
advocated in type II diabetes. Chromium has effects on lipid and carbohydrate metabolism but 
is poorly assimilated in the body. The PA in complex with chromium allows for better 
absorption of this metal (Grant et al., 2009).  
In experimental systems PA has been shown to elicit a number of effects within the body, 
particularly in immune system functioning. Macrophage effector functions were enhanced by 
PA through the increased gene expression of nitric oxide synthase (NOS) and expression of the 
macrophage inflammatory proteins (MIP) 1α and 1β mediated by interferon γ (IFNγ). Other 
studies have shown PA to possess anti-viral and anti-bacterial potential (Grant et al., 2009).  
 Investigators have also observed the effects of PA on cell cycle progression. Fernandez-Pol et 
al. (1977) showed that PA reversibly inhibits growth of cultured cells. Normal rat kidney cells 
were arrested in the G1 phase whereas transformed cells were arrested at various stages 
depending on the virus used to transform them. These results suggest that PA induces cell cycle 
arrest by interacting with a specific growth control mechanism that may involve NAD+ 
(Fernandez-Pol et al., 1977). Studies have also shown that PA possesses tumouricidal activity. 
Ogata et al. (1998) demonstrated that PA induces apoptosis and DNA fragmentation in the 
human promyelocytic leukaemia (HL-60) cell line (Ogata et al., 1998). In human myelogenous 
leukaemia cells (K562) PA was shown to cause DNA fragmentation and elevate levels of 








lymphocytes. This suggests that PA exerts some degree of tumour specificity                                     
(Ogata et al., 2000).  Most niacin related compounds exist as natural components in organisms, 
possessing unknown functions and warrant investigation as potential therapeutics                                           
(Ogata et al., 2000 ).  
1.4. Fusaric acid  
Fusaric acid (5-butylpicolinic acid) is a PA derivative and niacin related compound (Ogata et 
al., 2001) belonging to a novel class of nicotinic acid derivatives (Stack et al., 2014). The 
structure of FA is similar to that of PA as both contain pyridine rings, however FA has a 
substituted butyl group at position 5 (Figure 1.6) (Ogata et al., 2001). Fusaric acid is a common 
contaminant of maize and maize based food and feeds and is also found in grain where 
Fusarium spp. are isolated. Peculiarly, Bacon et al. (1996) showed that FA is synthesized by all 
strains of  Fusarium spp. surveyed. Thus, this secondary metabolite is different from other 
mycotoxins synthesized by various Fusarium spp., e.g. deoxynivalenol, and zearalenone, which 
are restricted to a few taxonomic groups among a species population. These investigators 
estimated that 11,665 species of plants, hundreds of which are agriculturally significant food 
plants, may serve as hosts of Fusarium spp. that are capable of producing FA. They concluded 
that FA is likely to be one of the most widely distributed mycotoxins produced by strains in the 










Figure 1.6: Structure of PA (A), FA (B) and Niacin (C). All three molecules are pyridine ring 
structures (Green box) however FA has a butyl group at position 5 (Red oval). Adapted from 




1.4.1. Toxic effects and mechanism of action  
Fusaric acid has been classed as a phytotoxin (Smith and MacDonald, 1991) and is known to 
possess low to moderate toxicity in human and animal models. This is of concern since FA 
shows synergism with other fusariotoxins (Wang and Ng, 1999). The enhancement of toxicity 
may be explained by the variety of Fusarium spp. and strains within the contaminated feed 
samples or due to multiple mycotoxins being produced by the same species. Regardless, 
analyses focusing solely on a single toxin is unlikely to show a good correlation between the 
concentration of any single mycotoxin and its induced toxicity (Bacon et al., 1996). 
1.4.1.1. In vitro toxicity  
The effect of FA on the transfer of electrons from iron (ferrous state) to molecular oxygen was 
investigated by measuring oxygen consumption rates. This study showed that FA is capable of 
repressing oxygen consumption. This repression is related to the efficiency of the electron 
transfer from Fe2+–ligand complex to the oxygen molecule (Hirai et al., 2005) suggesting that 
FA is capable of affecting the ETC.  
Experiments by Iwahashi et al (1999) were conducted to clarify the effects of FA on hydroxyl 
radical (OH-) formation, and focussed on the interactions between this mycotoxin and iron ions. 
These investigators found that FA, via Fenton chemistry, enhanced the formation of the 
hydroxyl radical through chelation of iron ion. It is proposed that the oxygen atom in the 
carboxyl group and the nitrogen atom in the pyridine ring are responsible for the chelation of 














The toxic effects of FA on rat liver mitochondria were studied by Telles-Pupilin and colleagues 
(1998). Their study showed that FA affected mitochondrial energy metabolism in at least three 
ways: (1) Inhibition of succinate-dehydrogenase, (2) inhibition of oxidative phosphorylation, 
and (3) inhibition of α-ketoglutarate-dehydrogenase. The inhibition of oxidative 
phosphorylation may be attributed to direct action of FA on the ATP-synthase complex without 
significantly inhibiting the ATP:ADP exchange (Telles-Pupulin et al., 1998).  
1.4.1.2. Animal toxicity 
Toxicity studies conducted in primiparous sows during the perinatal period showed that FA in 
synergism with other mycotoxins (deoxynivalenol and zearalenone) altered lymphocyte 
proliferation and apoptosis indicating that FA impairs the immune response. Feed intake was 
also decreased in the treated group (Malovrh and Jakovac-Strajn, 2010). The individual and 
combined effects of dietary diacetoxyscirpenol (DAS) and FA on turkey performance was 
determined by Fairchild et al. (2005). Their results showed that individually FA and DAS 
exhibit less toxicity than when administered together. This study also alluded to a protective 
effect of FA in DAS induced mouth lesions (Fairchild et al., 2005).  
An earlier study by Smith and MacDonald (1991) showed that pigs dosed with FA were 
lethargic and displayed brain neurochemical changes. This group also observed vomiting in 
swine treated with FA and concluded that FA induced toxic responses similar to Trichothecenes, 
proposing synergism of these mycotoxins (Smith and MacDonald, 1991). In a recent study, Yin 
et al. (2015) described a mechanism of notochord malformation in zebrafish after treatment with 
FA; an undulated notochord was attributed to chelation of copper by FA leading to aberrant 
lysyl oxidase activity. This enzyme is dependent on copper as a co-factor and cross-links 
collagen and elastin by catalysing allysine formation (Yin et al., 2015). These results implicate 
FA as a possible teratogen. 
1.4.1.3. Plant toxicity  
Toxicity induced by FA is better elucidated in plant models. Fusarium wilt is caused when the 
xylem of host plants is infected with the fungus Fusarium oxysporum, a known producer of FA. 
This mycotoxin accelerated the development of wilt disease by damaging cell membranes of 
leaves and causing non-stomatal water loss (Wang et al., 2015). A study by Wu et al (2008) 
showed that FA inhibited photosynthesis through reduction in chlorophyll mass and caused leaf 
wilting and mass necrosis (Wu et al., 2008). Fusaric acid has been shown to affect the 
development of corn seedlings by inhibiting root growth through interfering with metabolic 




Fusaric acid has the ability to change the proton electrochemical gradient across the plasma 
membrane, increase the loss of electrolytes, decrease cellular ATP levels, and inhibit some 
metalloenzymes (e.g., cytochrome oxidase) leading to respiratory impairment. Experiments by 
Singh and Upadhyay (2014) have shown that FA induced cell death is through the associated 
increase in ROS production and lipid peroxidation and the down-regulation of anti-oxidative 
enzymes (Singh and Upadhyay, 2014). Jiao et al (2014) demonstrated that mitochondrial 
dysfunction is a crucial event in the programmed cell death of tobacco suspension cells. Cells 
treated with FA exhibited a decrease in mitochondrial membrane potential, ATP content and 
anti-oxidant activities as well as increased hydrogen peroxide (H2O2)  and lipid peroxidation 
(LPO) (Jiao et al., 2014).  
1.4.2. Pharmacology  
Fusaric acid has also been shown to possess pharmacological activities that are apparent in the 
nervous and cardiovascular systems.  
By partially inhibiting tyrosine hydroxylase and inhibition of dopamine-β-hydroxylase (DBH) 
FA is able to affect neurotransmitter levels in the brain contributing to the toxicity of this 
mycotoxin (Wang and Ng, 1999). Dopamine-β-hydroxylase is required for synthesis of 
norepinephrine in the brain. Smith and MacDonald (1991) observed changes to swine 
neurochemistry after acute doses of FA. Their key findings included elevated levels of brain 
tryptophan, serotonin, and 5-hydroxyindole acetic acid as well as behavioural changes such as 
refusal to feed and lethargy. They attributed lethargy to enhanced action of the serotonergic 
nervous system resulting from elevated blood and brain tryptophan concentrations and the 
subsequent synthesis of serotonin, triggering the onset of sleep (Smith and MacDonald, 1991).  
Fusaric acid induced a reduction in blood pressure. A calcium salt of FA was tested in 
hypertensive patients for long term effects. In the first year both the systolic and diastolic blood 
pressures were lowered and no adverse effects were apparent. There were no consistent changes 
in heart rate or plasma volume. It was concluded that the hypotensive response was attained by 
reduction of the total peripheral vascular resistance index (Wang and Ng, 1999).  
More recently studies have shown FA to possess tumoricidal potential. In vitro studies on the 
HL-60 cell line revealed that FA induced apoptosis and DNA fragmentation. Although both PA 
and FA induced apoptosis in this study, FA was seen to effectively initiate apoptosis at lower 
concentrations compared to its parent compound. Niacin related compounds have low 




the addition of a fat soluble side chain to the pyridine ring may make the compound more 
effective (Ogata et al., 2001).   
Work by Stack JR et al (2004) elucidated a novel mechanism to treat head and neck squamous 
cell cancer (HNSCC). Fusaric acid can chelate divalent cations, especially zinc, and inactivate 
zinc finger proteins involved in DNA repair and protein synthesis. Their data demonstrated a 
suppressive effect of FA on two HNSCC cell lines. Fusaric acid reduced cell populations and 
arrested cell cycle progression. Although the exact mechanism is unknown FA is thought to 
cause DNA damage and inhibit DNA synthesis and repair. This may be brought on in part by its 
ability to chelate divalent cations from metalloproteins such as metallopanstimulin-1, which is a 
zinc finger protein (Stack et al., 2004). Many metalloproteins are involved in DNA repair and 
promotion of on-going cell growth and proliferation, chelation may be an alternate means of 
inducing cell cycle arrest or apoptosis. 
Ruda et al (2006) demonstrated that oral administration of FA inhibits tumour growth in an 
animal model for HNSCC. Following tumour cell inoculation mice were treated with FA or 
saline. The results of their study showed that FA treated mice had significantly slower tumour 
growth rates as well as decreased tumour mass when compared to control mice. This suggests a 
suppressive effect of FA on HNSCC xenografts (Ruda et al., 2006). The bioavailability of FA 
was determined by Stack et al., (2014) using male Sprague-Dawley rats. These investigators 
showed that 58% of the administered FA was available after oral administration suggesting that 
FA may be a viable oral therapeutic, however their study also revealed non-linear 
pharmacokinetic behaviour after administration of FA intravenously suggesting that metabolic 
enzymes and protein-FA interactions along with cellular transporters become saturated at a dose 
range of 10–75 mg/kg (Stack et al., 2014).  
1.5.  Mitochondria  
Mitochondria are double membrane organelles and are sometimes described as “cellular power 
plants” due to their ability to convert organic material into energy (Kakkar and Singh, 2007). 
These organelles are responsible for the bulk of ATP production through various means 
including the Kreb‟s cycle, β-oxidation of fatty acids and oxidative phosphorylation (OXPHOS) 
(Wang et al., 2013). They also play key roles in NADPH synthesis, DNA repair and metabolic 
pathways as well as playing a major role in cell death  (Kakkar and Singh, 2007). Mitochondria 
are also the major producers of endogenous ROS in human cells, serving as „redox messengers‟ 




Mitochondria contain four separate compartments, an inner membrane, an outer membrane, a 
matrix space enclosed by the inner membrane and an inter-membrane space between the inner 
and outer membranes. The Krebs‟s cycle occurs in the matrix of the mitochondria and the 
production of ATP occurs at the inner membrane (Champe et al., 2005).  
The Krebs‟s cycle participates in several mitochondrial processes. It is the final pathway where 
oxidative metabolism of macromolecules (carbohydrates, protein and fatty acids) converge to 
produce the reducing equivalents NADH and flavin adenine dinucleotide (FADH2), these 
reducing equivalents feed into the ETC (Champe et al., 2005). 
Production of ATP occurs via the ETC. This chain is divided into multi-enzyme complexes that 
are embedded in the inter-mitochondrial membrane. They are complex I: NADH CoQ 
reductase, complex II: succinate-CoQ reductase, complex III: reduced CoQ cytochrome c 
reductase, complex IV: cytochrome c oxidase and complex V: ATP synthase which is made up 
of the F1 and F0 units (Kakkar and Singh, 2007).   
The ETC is used to generate an electrochemical proton gradient across the inner membrane 
which is required for OXPHOS. Complex 1 (NADH hydrogenase) oxidizes NADH to NAD+ 
and initiates the process of electron flow. Electrons flow sequentially through complex III, 
cytochrome c and finally through complex IV where bound oxygen is reduced to water. During 
the process of electron flow from NADH to molecular oxygen, each of the three complexes (I, 
III, and IV) catalyzes the translocation of protons across the mitochondrial inner membrane. 
During OXPHOS the F0 sub-unit transmits energy from the electrochemical proton gradient to 
the F1 unit promoting ATP synthesis. This gradient facilitates the entry of adenosine 
diphosphate (ADP) and inorganic phosphate (Pi) into the matrix space. The ATP synthase 
complex then binds ADP to Pi producing ATP (Figure 1.8). The remaining part of the gradient 
is used to generate NADPH through a transmembrane enzyme called transhydrogenase, which 
is not part of the OXPHOS apparatus (Kakkar and Singh, 2007).  
Iron-sulphur clusters and heme are iron containing prosthetic groups that catalyse the transfer of 
electrons in a variety of electrochemical reactions including those of the ETC. Mitochondrial 
ETC complex I, contains iron-sulphur clusters whereas complex II and III contain both heme 
and iron-sulphur clusters. Heme groups can also be found in cytochrome c and complex IV. 
Heme and iron-sulphur clusters only become biologically active when they are linked to a 
polypeptide backbone, which then adopts correct folding and conformation (Atamna et al., 
2002). Aconitase is a crucial enzyme of the Kreb‟s cycle and is responsible for the inter-




susceptible to oxidative inactivation lending itself to play a vital role as a mitochondrial redox 
sensor  (Liu and Kamp, 2011). Thus both heme and iron-sulphur clusters are essential for the 














Figure 1.8: The electron transport chain is a sequence of protein complexes through which 
electrons flow in a unidirectional manner from complex I to complex V culminating in the 
synthesis of ATP (prepared by author). 
1.5.2. Mitochondrial biogenesis 
Mitochondrial biogenesis is defined as the growth and division of pre-existing mitochondria 
(Jornayvaz and Shulman, 2010 ) since they cannot be generated de novo (Battersby and Richter,  
2013). Mitochondria are tubular in shape and changes to morphology are driven by fission, 
fusion and translocation. These processes allow for the proper organisation of the mitochondrial 
network during biogenesis (Ventura-Clapier et al., 2008). Mitochondrial fission is essential for 
the equal distribution of mitochondria in daughter cells during mitosis (Boland et al., 2013).  
These organelles possess their own genome and can auto-replicate (Jornayvaz and Shulman, 
2010 ). Mitochondrial DNA (mtDNA) is circular and encodes 13 mRNAs, 22 tRNAs and 2 




proteins including those involved in mitochondrial biogenesis itself, are encoded by the nuclear 
genome (Yoboue and Devin, 2012). The co-ordinated synthesis and import of proteins encoded 
by the nuclear genome is required for correct mitochondrial biogenesis (Jornayvaz and 
Shulman, 2010 ). Because a major portion of mitochondrial proteins are encoded by nDNA 
(Figure 1.9), a variety of mechanisms exist to target, import, and correctly assemble these 
proteins thereby ensuring proper mitochondrial function and morphology (Ventura-Clapier et 





Figure 1.9: The number of complex subunits encoded by mitochondrial (mtDNA) and nuclear 
(nDNA) genomes (Yoboue and Devin, 2012). 
1.5.2.1. Transcription factors involved in mitochondrial biogenesis 
The replication and transcription of mtDNA is driven by mitochondrial transcription factor A 
(Tfam) (Wu et al., 1999). This is a nuclear encoded transcription factor that binds to an 
upstream enhancer of the promoter sites of the two mitochondrial DNA strands (Ventura-
Clapier et al., 2008). Tfam helps regulate mtDNA number (Piantadosi and Suliman, 2006) and 
Tfam expression is co-ordinated and regulated by a highly specific set of transcription factors 
mentioned below.  
The nuclear respiratory factors (NRF-1 and NRF-2) are nuclear transcription factors that direct 
respiratory gene expression in cells. Both NRF-1 and NRF-2 are regulators for subunits of 
complex I, complex II, complex III, cytochrome oxidase and ATP synthase. These transcription 
factors also encode proteins involved in mtDNA transcription and replication and genes 
required for mitochondrial protein import (Yoboue and Devin, 2012).  
The peroxisome proliferator-activated receptor gamma co-activator (PGC-1) family of co-
activators (PGC-1α, PGC-1β and PRC) are highly versatile and have the ability to interact with 
a plethora of transcription factors allowing them to mediate a host of biological programs (Lin 
et al., 2005). Indeed, PGC-1α plays a pivotal role in mitochondrial biogenesis by co-regulating 
other transcription factors (Scarpulla et al., 2012). PGC-1α has emerged as the master regulator 




the activity of several transcription factors involved in mitochondrial biogenesis by binding to 
transcription factors NRF-1, NRF-2 and estrogen-related receptor α (ERRα) among others 
(Yoboue and Devin, 2012). Initially, the NRF-1 transcription factor was identified as a target for 
PGC-1α induced mitochondrial biogenesis. PGC-1α can trans-activate NRF-1 mediated gene 
expression. PGC-1α also targets ERRα along with NRF-2 in regulating respiratory genes such 
as cytochrome c. Therefore NRF-1 and NRF-2 are thought to act downstream from both PGC-
1α and ERRα in facilitating respiratory gene expression (Scarpulla, 2011).  
The cyclic AMP (cAMP) response binding element protein (CREB) is a transcription factor that 
promotes the transcription of cAMP response element (CRE) regulated genes in response to 
different cellular signals. Phosphorylation of CREB by cAMP-dependent protein kinase (protein 
kinase A; PKA), as well as by Ca2+ -dependent and other protein kinases, is required for 
transcriptional activation of CREB. De Rasmo et al., (2009) showed that CREB is imported into 
the mitochondria by a membrane potential dependent mechanism and this import may be 
facilitated by heat shock protein 70 (HSP70). Once in the mitochondria, phosphorylated CREB 
(p-CREB) promotes protein synthesis of mitochondrial OXPHOS subunits by exerting its 
effects on the mtDNA (Rasmo et al., 2009).  
1.5.2.2. Integration of mitochondrial biogenesis and oxidative stress  
Recent evidence shows a link between mitochondrial biogenesis and oxidative/mitochondrial 
stress responses. Oxidative stress is defined as the presence of ROS in excess of the anti-oxidant 
buffering capacity (Amira, 2010). Oxidative stress damages mitochondria impairing their ability 
to produce ATP ultimately leading to cell death. Many cellular programmes exist to protect 
mitochondrial integrity and to replace dysfunctional mitochondria with better suited organelles 
through replication of highly functional sub-populations (Piantadosi and Suliman, 2012).  
Insight into the underlying mechanism of interactions between ROS signalling and 
mitochondrial biogenesis were elucidated by Piantadosi and Suliman (2006). Their study 
showed that lipid hydroperoxide regulates Tfam expression via AKT activation and its 
phosphorylation of NRF-1. This promotes the translocation of NRF-1 and binding to the Tfam 
promoter (Piantadosi and Suliman, 2006). Furthermore the induction of PGC-1α expression is 
mediated by CREB binding to the PGC-1α promoter during oxidative stress conditions (St-
Pierre et al., 2006) further enhancing mitochondrial biogenesis. These results show that a link 




Mitochondrial biogenesis can be activated by mitochondrial ROS via retrograde signalling from 
damaged mitochondria to the nucleus. These stress cues lead to up-regulation of nuclear 
transcriptional responses and subsequent encoding of mitochondrial and anti-oxidant proteins. 
The eliciting of such responses serve to compensate for mitochondrial dysfunction and dampen 
oxidative stress (Piantadosi and Suliman, 2012).   
1.5.3. Mitochondrial stress responses  
1.5.3.1. Sirtuins  
The sirtuins belong to a conserved family of proteins that depend on NAD+ for their deacetylase 
activity. Although sirtuins are considered as histone deacetylases (HDACS) because of their 
NAD+ dependence, they are functionally different from other HDACS as they carry out 
deacetylation via a two-step reaction that  encompasses the consumption of NAD+ and release of 
nicotinamide (NAM), 1-O-acetyl-ADP-ribose (1-OAADPR), and the deacetylated substrate. 
These deacetylases are involved in a range of biological functions including DNA repair, 
control of metabolic enzymes and apoptosis (Parihar et al., 2015).  
In mammalian cells seven sirtuins exist (SIRT1-SIRT7), with each having distinct flanking C 
and N terminal extensions. These variations allow for sub-cellular localisation of SIRTs as 
described in table 1.  
Table 1: The members of the Sirtuin family are found in different cell compartments allowing 













1.5.3.2. Mitochondrial sirtuins  
Mitochondrial sirtuins act as energy sensors due to their dependence on NAD+ as a co-factor. 
The three mitochondrial sirtuins: SIRT3, SIRT4, and SIRT5 are localized mainly in the 
mitochondrial matrix due to the presence of a mitochondrion targeting sequences in their N 
termini. Among these SIRT3 is the major mitochondrial deacetylase that regulates global 
mitochondrial lysine acetylation status (Lombard et al., 2007) and maintains the integrity of this 
organelle (Tao et al., 2015). Initially the full length SIRT3 (44 kDa) is synthesized as an 
enzymatically inactive protein which is activated on its translocation to the mitochondria as a  
28 kDa protein by a mitochondrial peptidase present in mitochondrial matrix. Once in the 
mitochondria SIRT3 regulates many important processes and is thus highly expressed in 
metabolically active organs such as the liver, brain and kidney (Parihar et al., 2015).   
1.5.3.3. Sirtuin structure  
All sirtuins contain a highly conserved catalytic core domain which has a structurally 
homologous and large NAD+/NADH binding Rossmann-fold domain, zinc-binding domain and 
numerous loops that form a distinct and extended cleft. This cleft attaches the two domains 
where the NAD+ and acetyl lysine containing protein substrates enter and bind to the enzyme for 











Figure 1.10: Structure of SIRT3 in complex with a substrate (encircled in blue)           





1.5.3.4. Regulation of SIRT3 activity 
The expression of SIRT3 is dependent on the oxidative status of the cell, with stress conditions 
leading to the up-regulation of this mitochondrial protein (Weir et al., 2013). Mammalian 
sirtuins are not only regulated by NAD/NADH ratio or cellular stressors, but also by 
endogenous proteins involved in signal transduction and transcription, as well as by a number of 
microRNAs (Nogueiras et al., 2012). 
 The co-factor NAD+ is an absolute requirement for the deacetylase activity of SIRT3. This 
places SIRT3 at the nexus of energy metabolism in the mitochondria (Nogueiras et al., 2012). 
The NAD+ derived within a cell is via two main pathways: de novo synthesis from the amino 
acid tryptophan and via the salvage of NAM back to NAD+ (Grant et al., 2009, Revollo et al., 
2004). In humans, the rate-limiting step of the NAD salvage pathway is catalysed by  
nicotinamide phosphoribosyltransferase (NAMPT), which converts nicotinamide to 
nicotinamide mononucleotide (NMN) (Nogueiras et al., 2012). This reaction is followed by an 
NMN adenylyltransferase (NMNAT) dependent formation of NAD+ (Figure 1.11) (Kleszcz et 
al., 2015). A study by Revollo et al., (2004) showed that NAD biosynthesis mediated by 
NAMPT, regulates the function of  sirtuins and plays an important role in controlling various 
biological events in mammals (Revollo et al., 2004).  
Sirtuins are also regulated by their reaction product, NAM, which inhibits sirtuin reactions 
through a base exchange pathway where rebinding of the reaction product to the enzyme 
accelerates the reverse reaction (Guan et al., 2014). However, through experimental kinetic and 
computational studies Guan et al., (2014) showed that NAM inhibition of SIRT3 involved 
competition between the inhibitor and enzyme co-factor NAD+  (Figure 1.11), conflicting to the 






















Figure 1.11: SIRT3 reaction and regulation (prepared by author).  
1.5.4. Mitochondrial function is regulated by SIRT3 
The mitochondria are a hub of metabolic activity for carbohydrate, protein and fatty acid 
processing. During metabolic activities most of the mitochondrial proteins undergo post-
translational modifications with lysine acetylation serving as a link between acetyl CoA 
metabolism and cell signalling (Parihar et al., 2015). Indeed a vast majority of mitochondrial 
proteins are found to be acetylated (Gibellini et al., 2014a). Sirtuins, and in particular SIRT3 is 
therefore well positioned to regulate many aspects of mitochondrial function through removal of 
acetyl CoA from lysine residues through its deacetylase activity.  
1.5.4.1. Fatty acid metabolism  
The balance between fatty acid synthesis, lipid oxidation and its storage are the processes 
involved in fatty acid metabolism. Acetyl CoA synthetase is a substrate for SIRT3 (Tao et al., 
2015). Schwer et al (2006) reported that human acetyl-CoA synthetase 2 (AceCS2) is a 
mitochondrial matrix protein that can be reversibly acetylated at Lys-642. The mitochondrial 
SIRT3 interacts with AceCS2 and deacetylates Lys-642 both in vitro and in vivo, thereby SIRT3 
regulates fatty acid synthesis by activating the acetyl-CoA synthetase activity of AceCS2. The 
acetyl-CoA synthetase reaction, results in the formation of acetyl-CoA from acetate, ATP, and 
CoA, proceeds in two steps. In the first step, acetate is activated to acetyl-adenosine 
monophosphate (acetyl- AMP). In the second step, acetyl-AMP is converted to acetyl-CoA by 
the thioester bond-forming activity of ACS, and acetyl-CoA and AMP are released sequentially 




Fatty acid oxidation is enhanced by SIRT3 deacetylation of long-chain acyl-CoA 
dehydrogenase (LCAD) which is generally hyperacetylated at one lysine residue, K42  (Parihar 
et al., 2015) and mitochondrial 3-hydroxy3-methylglutaryl CoA synthase 2 (HMGCS2),which 
catalyses the process of lipid utilization (Shimazu et al., 2010). This deacetylase also prevents 
the accumulation of fatty acids in the mitochondria by acting alongside the adenosine 
monophosphate activated protein kinase (AMPK), which phosphorylates acetyl CoA 
carboxylase (ACC) the rate limiting enzyme in fatty acid synthesis (Shi et al., 2010).    
1.5.4.2. Kreb’s cycle, Electron transport chain and oxidative phosphorylation 
The protein complexes of the ETC and OXPHOS are the most heavily acetylated. Since SIRT3 
is the major mitochondrial deacetylase it interacts with proteins of the ETC, modifying and 
improving their activity (Parihar et al., 2015). The activity of complexes I and II of the ETC was 
significantly decreased in SIRT3 knock-out mouse embryonic fibroblasts (MEFs). This study 
also eluded to a role of SIRT3 in complex III regulation (Kim et al., 2010). Complex V of the 
ETC was shown to be a target of SIRT3 with deacetylation of this complex increasing its 
activity (Finley et al., 2011). The importance of SIRT3 on energy homeostasis was 
demonstrated by Ahn et al (2008). They showed that the knock-out of SIRT3 resulted in a 30% 
decrease to intracellular ATP levels (Ahn et al., 2008).  
A study by Finley et al., (2011) showed that SIRT3 directly interacts with succinate 
dehydrogenase (SDH) sub-units A and B. The SIRT3 mediated deacetylation of this complex 
serves to increase enzyme activity. The SDH complex is a member of both the ETC and Kreb‟s     
cycle (Finley et al., 2011), this shows that SIRT3 is a regulator of FAD/FADH2 metabolism. 
The efficient deacetylation of the Kreb‟s cycle enzyme isocitrate dehydrogenase (ICDH) was 
observed by Schlicker et al., (2008). Their study revealed that SIRT3 interacts with ICDH and 
increased its activity through deacetylation of lysine211 or 212 (Schlicker et al., 2008 ).  
1.5.4.3. Integration of oxidative stress and mitochondrial stress responses 
The primary defence against oxidative stress is the detoxifying enzymes that scavenge excess 
ROS. These include catalase and superoxide dismutase. The role of PGC-1α in ROS metabolism 
was explored by St-Pierre et al., (2006). They reported that the expression of mitochondrial 
ROS-detoxifying enzymes including GPx1 and SOD2 increases with PGC-1α. They showed 
that by increasing PGC-1α levels neural cells in culture were protected from oxidative stressor- 
mediated death. These studies revealed PGC-1α‟s role as a broad and powerful regulator of 




Recent evidence has shown that PGC-1α links mitochondrial stress responses to oxidative 
stress. Oxidative stress increases the expression of PGC-1α, which induces SIRT3 expression 
through activation of ERR-α. In turn, SIRT3 stimulates PGC-1a expression via pCREB, thereby 
forming a positive feedback loop and increasing anti-oxidant defence (Kong et al., 2010).  
In the mitochondria SIRT3 is able to deacetylate and increase the activity of SOD2. Two recent 
studies (Tao et al., 2010, Qiu et al., 2010) indicated that SOD2, the primary mitochondrial 
superoxide detoxification enzyme, contains a lysine residue that can be deacetylated by SIRT3 
overexpression. Deeper analysis by Tao and co-workers (Tao et al., 2010) showed that lysine 
122 is directly deacetylated by SIRT3. When lysine 122 was altered to arginine (to mimic the 
deacetylated state; MnSODK122-R), enzymatic activity was increased, intracellular ROS were 
decreased, and stress-induced genomic instability was prevented. In contrast, when lysine 122 
was altered to a glutamine (to mimic the acetylated state; MnSODK122-Q), SOD2 activity was 
decreased, proposing that acetylation status directs SOD2 enzymatic activity and cellular ROS 
levels (Tao et al., 2010). Increased ROS levels in SIRT3 knock-out mouse embryonic 
fibroblasts were also observed by Kim et al., (2010). Furthermore, SIRT3 was found to 
deacetylate FOXO3a and allows its translocation to the nucleus (Kim et al., 2010). The 
mammalian FOXO transcription factors are targeted by sirtuins under conditions of oxidative 
stress and determine their subcellular localisation, protein stability, and transcriptional activity 
leading to up-regulation of anti-oxidant expression such as catalase (Rajendran et al., 2011). 
Taken together the results of these studies outline a crucial role for SIRT3 in dampening 
oxidative stress. 
Besides its roles as a regulator of ROS scavenging, SIRT3 plays an important role in 
maintaining mitochondrial structure and function through the deacetylation of Lon protease 
(LON). Gibellini et al., (2014) found that LON and SIRT3 co-localise and co-
immunoprecipitate in breast cancer cells and SIRT3 loss increased the acetylation and protein 
expression of LON. Their study suggests that SIRT3 deacetylates LON most likely at lysine 917 
(Gibellini et al., 2014a). LON is also regulated at the transcriptional level by Nrf2  (Ngo et al., 
2013 ). This protease is a human stress protein that removes and degrades oxidatively damaged 
proteins in the mitochondria preventing their cross linking and aggregation. A study by Ngo and 
Davies (2009) showed that loss of  LON leads to increased protein damage and mitochondrial 
dysfunction (Ngo and Davies, 2009 ).  
The catalytic activity of LON is ATP dependent and serves to not only remove damaged 




protein or protein complexes through selective sub-unit degradation (Venkatesh et al., 2012). 
The steps involved in proteolytic protein degradation by LON are depicted in Figure 1.12.  
LON is a mitochondrial DNA binding protein that interacts with single stranded DNA only in 
mammalian cells. Human LON associates with mtDNA sequences bearing a minimum of 4 
adjoining guanine residues that have a tendency to form G-quadruplexes, which are four-
stranded intra- or inter-molecular structures with a tetrad organization of guanines. The binding 
of mtDNA and LON is a physiological function of this protease and may provide a mechanism 
for recruitment of it to sites in mtDNA where it can degrade or process proteins involved in 
mtDNA and mitochondrial RNA metabolism. Furthermore the binding of mtDNA by LON may 
directly promote or inhibit the processivity or timing of transcription and/or replication 
(Venkatesh et al., 2012). Matsushima et al., (2010) investigated the role LON protease plays in 
regulating mtDNA transcription and maintenance. Their results show that LON modulates 
biogenisis of mtDNA through selective degradation of Tfam. Thus stabilising the Tfam∶mtDNA 
ratio by degradation of excess Tfam (Matsushimaa et al., 2010). Under oxidative stress 
conditions LON binds to fewer mtDNA sites. Decreased  LON binding may occur due to DNA 
repair and replication proteins being recruited to the mitochondrial genome and competing with 
Lon for binding sites. Alternatively, Lon may be recruited away from the genome to degrade 
other proteins that become oxidativelydamaged. These results suggest roles for LON in linking 
protein and mtDNA quality control (Lu et al., 2007).  
LON can also act as a chaperone, independent of its proteolytic activity and promote the 
assembly of cytochrome c oxidase subunits (Bota et al., 2005 ) with downregulation of  LON 
resulting in impaired respiratory function. Gibellini and colleagues (2014) showed that 
decreased LON levels impairs mitochondrial function in colorectal cancer cells with 
concomitant decreased expression of mitochondrial proteins of which some were related to 
























Figure 1.12: General mechanism for the recognition and degradation of protein substrates by 
LON. Step 1: recognition and binding of a sequence found in the protein substrate. Step 2: 
unfolding of structured protein substrates by the AAA+ domains of the holoenzyme, this 
requires ATP -binding and -hydrolysis. Unfolded substrates or peptides bypass this step. Step 3: 
translocation of unfolded polypeptides or short peptide sequences into the degradation chamber, 
which also requires ATP -binding and -hydrolysis. Step 4: peptide bond cleavage resulting in 
the generation of small peptide products. Continous substrate unfolding and translocation are 
required to degrade substrates completely (Venkatesh et al., 2012). 
1.6. Cellular responses to oxidative stress  
Cells are able to sense macromolecular damage and respond to stress-induced damage, thereby 
re-establishing homeostasis. Following the initiation of oxidative stress, the basic leucine zipper 
transcription factor, nuclear factor-erythroid 2-related factor 2 (Nrf2) is activated at the 
posttranscriptional level. Nrf2 is the master transcription factor plays a pivotal role in cell 
defence against oxidative stress by modulating the anti-oxidant response programme (Keum and 




xidants and enzymes involved in phase II detoxification and glutathione biosynthesis (Dinkova-
Kostova et al., 2005).   
Under non-stressed conditions, Nrf2 is sequestered in the cytoplasm by Kelch-like ECH-
associated protein 1(Keap1). This complex directs Nrf2 polyubiquitination and degradation by 
functioning as an adaptor of the Cul3 based E3 ligase (Dinkova-Kostova et al., 2005). Upon 
oxidative stress, Nrf2 is liberated from Keap1 and enters the nucleus, to stimulate the expression 
of anti-oxidant response element (ARE) containing genes (Sano and Fukuda, 2008, Keum and 
Choi, 2014). This prevents oxidative damage to cellular components and organelles.  
A study by Dinkova-Kostova et al. (2005) sought to determine how the kinetics and 
stoichiometry of Keap1 govern its susceptibility to inducer mediated modifications. Their 
results revealed that Keap1 contains 0.9 zinc atoms per monomer and established that zinc is 
bound to the reactive cysteine thiols of Keap1and that inducers displace this metal. They also 
revealed that zinc binding is highly dependent on these cysteine residues and that mutation of 
these residues to alanine decreased binding by 2 fold. Thus, regulation of the phase II response 
involves chemical modification of critical cysteine residues of Keap1, whose reactivity is 
modulated by zinc binding. Keap1 is a zinc-thiol protein enabled with a switch controlled by 
both metal-binding and thiol reactivity. Under non-stressed conditions Keap1 binds zinc that is 
coordinated in part by reactive cysteine residues (Cys). In this conformation, Keap1 binds Nrf2 
and marks the transcription factor for degradation. Upon inducer sensing, the zinc is released 
and the reactive cysteine residues are modified by alkylation, oxidation, or thiol-disulfide 
interchange, leading to a conformational change that separates the Kelch domains and releases 
Nrf2 (Figure 1.13) allowing its nuclear translocation and enhanced expression of phase 2 




















Figure 1.13: Role of zinc in mediating Nrf2 release (Dinkova-Kostova et al., 2005). 
1.7. Mitochondria in hepatotoxicity  
Damage to hepatocytes can be cytotoxic, genotoxic or metabolic. Cytotoxicity involves 
morphological changes to the hepatocyte often accompanied by the leakage of hepatic enzymes 
to the extracellular environment. Gonotoxins cause DNA damage and often lead to the 
development of hepatocarcinomas. Finally, toxins are also able to alter cellular metabolism of 
hepatocytes and can lead to cell death (Castell et al., 1997).  
Hepatotoxicity often originates from the alteration to metabolic processes within the cell. Some 
toxins directly inhibit enzyme activity or ion transport or compete with cellular metabolites for 
metabolic pathways in hepatocytes. Other toxins can affect the ATP status of the cell by 
increasing ATP consumption or decreasing ATP synthesis (Castell., 1997).   
The mitochondria constitute an important target for hepato-toxins. Even a mild dysfunction of 
mitochondria in the liver can cause hepatic injury.  Dysfunctional mitochondria lead to the 
excessive generation of ROS, this causes damage to cellular components including lipids, 
protein and nucleic acids (Esposti et al., 2012). Mitochondria play a pivotal role in apoptosis. 
This is an energy dependent form of programmed cell death. The mitochondria are the initiators 
of the intrinsic apoptotic programme which relies on stimulators opening the mitochondrial 
permeability transition (MPT) pore leading to the loss of the mitochondrial transmembrane 
potential and release of two main groups of normally sequestered pro-apoptotic proteins from 
the intermembrane space into the cytosol. The first group consists of cytochrome c, second 




HtrA2/Omi. These proteins activate the caspase-dependent mitochondrial pathway. Cytochrome 
c binds and activates apoptosis protease activation factor (APAF-1) as well as procaspase-9, 
forming an “apoptosome”. The clustering of procaspase-9 in this manner leads to caspase-9 
activation. Caspase 9 subsequently cleaves pro-caspase 3 leading to caspase 3 activation. 
Smac/DIABLO and HtrA2/Om are reported to promote apoptosis by inhibiting inhibitors of 
apoptosis proteins (IAP) activity (Elmore, 2007).  
The IAP family of proteins shares a conserved module known as the baculovirus inhibitor of 
apoptosis protein repeat (BIR) domain. The BIR is a zinc finger protein characterized by the 
conservation of critical Cystine and Histidine residues that coordinate a zinc atom. A total of six 
major IAPs have been identified in humans, of which four directly inhibit the activity of 
caspases (Riedl et al., 2001).  
Structural analysis of X-linked mammalian inhibitor of apoptosis protein   (XIAP) reveals that 
the segment inhibiting caspase 3/7 is distinct from the segment inhibiting caspase 9 activity with 
the BIR2 and BIR3 domains associated with inhibiting the effector and initiator caspase 
respectively (Riedl et al., 2001).   
The second group of pro-apoptotic proteins, apoptosis inducing factor (AIF) and endonuclease 
G are released from the mitochondria during apoptosis, but this is a late event that occurs after 
the cell has committed to die. AIF translocates to the nucleus and causes DNA fragmentation 
and condensation of peripheral nuclear chromatin. Endonuclease G also translocates to the 
nucleus where it cleaves nuclear chromatin to produce oligonucleosomal DNA fragments. AIF 
and endonuclease G both function in a caspase-independent manner (Elmore, 2007).  
Dysfunction of this critical organelle affects energy balance and is a crucial factor in cell death 
(Castell., 1997). Hepatotoxicity studies most often deal with a form of cell death termed lytic 
necrosis. This form of cell death is characterised by membrane lysis and inflammation. (Castell,. 








CHAPTER 2: MATERIALS AND METHODS 
2.1. Materials  
The HepG2 cell line was purchased from Highveld Biologicals (Johannesburg, South Africa 
(SA). All tissue culture reagents, the Caspase-Glo® 9 and 3/7 Assay and ATP assay (Promega) 
were obtained from Whitehead Scientific (Johannesburg, SA). Western blot reagents were 
purchased from Bio-Rad ((Hercules, CA, USA). Quantitative PCR (qPCR) primers were 
synthesized by Inqaba Biotech. All other reagents were purchased from Merck (Darmstadt, 
Germany).  
2.2. Cell culture and exposure protocol 
2.2.1. Cell culture  
The HepG2 cell line is derived from a liver hepatocellular carcinoma of a 15 year old Caucasian 
male. These cells are adherent, non-tumorigenic and are epithelial in nature. There is no 
evidence of the HBV genome in this cell line  (ATCC, 2014). This cell line is considered a 
model for the investigation of toxicity since it retains the ability to undergo detoxification 
responses as well as retaining many functions often lost by primary hepatocyte cultures(Mersch-
Sundermann et al., 2004). The HepG2 cells were cultured in complete culture media (CCM) 
consisting of Eagle‟s minimum essential medium supplemented with 1% penstrepfungizone, 1% 
L-glutamine and 10% foetal bovine serum. Cultures were maintained at 37°C with 5% CO2.  
2.2.2. Exposure protocol  
For the methyl thiazol tetrazolium (MTT) assay, cells were seeded into a 96-well microtitre 
plate, allowed to attach overnight and treated with FA solution (0-500μg/ml) for 24h. The range 
and time frame utilized is based on previous work (Jiao et al., 2014, Telles-Pupulin et al., 1998, 
Ruda et al., 2006). The chosen time period will provide a suitable measure for acute exposure. 
.For all other assays cells were cultured to 90% confluency in 25cm3 tissue flasks and treated 
with FA at the half maximal inhibitory concentration (IC50) as determined by the cell viability 
assay. The assays were performed at the IC50 of cell viability since lower concentrations might 
result in cytotoxic effects being underestimated, while higher concentrations could result in 
experimental by-products. An IC50 provides a workable concentration. 
2.2.2.1. Use of controls  
For western blot and q-PCR experiments a negative control and positive control was used. The 




nicotinamide. The significance for using the positive control was to show an expected outcome 
in relation to SIRT3 loss.  
2.3. Metabolic activity  
2.3.1. MTT assay 
2.3.1.1 Introduction  
The colorimetric MTT assay was used to determine cell viability. Methylthiazol tetrazolium is a 
yellow water soluble dye that is reduced by metabolically active cells through the activity of 
dehydrogenase enzymes. This leads to formation of an insoluble intracellular purple formazan 
product which can then solubilized and quantified by spectrophotometry.  
This reaction only occurs in metabolically active cells and is dependent on the production of the 
reducing equivalents nicotinamide adenine dinucleotide (NADH) and flavin adenine 
dinucleotide (FADH2) produced in the Krebs‟s cycle (Figure 2.1). This assay is a measure of 
metabolic activity in the cell. The intensity of the formazan product is directly proportional to 





























Figure 2.1: Production of reducing equivalents by the Kreb‟s cycle to drive the ETC and 










Figure 2.2: Schematic representation of the principle behind the MTT assay                      






Approximately 20,000 cells were seeded per well in triplicate and incubated with a range of FA 
concentrations (0, 25, 50, 100, 250, 350 and 500 µg/ml) for 24 h. Cells were then rinsed twice 
with 0.1M phosphate buffer saline (PBS) and incubated with MTT salt solution (5mg/ml in 
0.1M PBS) and complete culture medium for 4h (37ºC). Subsequently, 100μl of dimethyl 
sulphoxide (DMSO) was added to each well and incubated for 1h (37ºC). The optical density of 
the formazan product was read using a spectrophotometer (Bio-tek μQuant) at 570 nm with a 
reference wavelength of 690 nm. The results were expressed as percentage cell viability vs. 
concentration of FA, from which the IC50 was determined.   
2.3.2. ATP assay 
2.3.2.1. Introduction  
Adenosine triphosphate is the major energy currency molecule of the cell and its production is 
essential to carry out various cellular processes. The mitochondria are the predominant 
producers of ATP through the electron transport chain coupled to oxidative phosphorylation as 
well as through substrate level phosphorylation. Glycolysis also contributes to ATP production 
under certain conditions. These processes ensure optimum production of ATP necessary for cell 
survival.  
To determine ATP concentration, the CellTire Glo™ (Promega) assay was used. This assay 
employs bioluminescence to measure ATP levels in cells and is based on the luciferase reaction 
in which luciferin is mono-oxygenated to oxy-luciferin in the presence of Mg2+, molecular 
oxygen and ATP. This results in the release of energy in the form of luminescence (Figure 2.3). 





















Figure 2.3: Principle of the CellTire Glo™ assay used to quantify intracellular ATP 
concentration (prepared by author). 
2.3.2.2. Protocol  
Approximately 20,000 cells were aliquoted per well in a microtitre plate (triplicate) to which 50 
µl CellTire Glo™ reagent (Promega, Madison, USA) was added and left in dark (30 mins, RT) 
to allow reaction to occur. The luminescent signal was then read using a Modulus™ microplate 
luminometer (Turner Biosystems, Sunnyvale, USA). The signal is directly proportional to 
intracellular ATP concentration. Results are expressed as mean relative light units (RLU). 
2.4. Oxidative stress – Lipid peroxidation  
2.4.1. Introduction  
Lipid peroxidation is defined as the oxidative deterioration of lipids of which the unsaturated 
variety is most affected due to their double bond between carbon atoms. Many cellular 
organelles incorporate lipids into their membranes, thus damage caused by peroxidation is 
detrimental to cell function and survival (Devasagayam et al., 2003).  
Lipid peroxidation is initiated by oxidizing agents such as free radicals that remove hydrogen 
atoms from poly-unsaturated fatty acids (PUFAs). This brings about a chain reaction 
mechanism of lipid peroxidation which involves an initiation step, a propagation step and 
termination step (Ayala et al., 2014, Devasagayam et al., 2003).                                                                                                       
The thiobarbituric acid reactive substances (TBARS) assay was used to quantify the 




oxidative stress. One molecule of MDA reacts with two molecules of thiobarbituric acid (TBA) 
at high temperature and low pH resulting in formation of a pink chromagen (Figure 2.5). 
During initiation, oxidizing agents remove hydrogen atom forming a lipid radical; this radical 
can be stabilized by a molecular rearrangement to form a conjugated diene (step 1). In the 
propagation phase, lipid radical rapidly reacts with oxygen to form a lipid peroxy radical (step 
2) which removes a hydrogen from another lipid molecule generating a new lipid radical (step 
3). In the termination reaction, anti-oxidants donate a hydrogen atom to the lipid peroxy radical 















Figure 2.4: Chain reaction of lipid peroxidation. Step1 – initiation, step 2 and 3 – Propagation,                         
step 4 – Termination (Ayala et al., 2014).  
2.4.2. Protocol  
The following reagents were added to a set of test tubes: 200μl of 2% H3PO4, 400μl of 7% 
H3PO4, 200μl of TBA/butylated hydroxytoluene (BHT) solution and 200μl of 1M HCL. 
Supernatants of treated cells were recovered and 100μl of cell supernatant was then added to 
each test tube in triplicate. A positive control was prepared by adding 1μl of MDA to a test tube. 




tube, vortexed for 10 secs and allowed to separate into two distinct phases. The upper butanol 
phase (100μl, triplicate) was then transferred to a 96-well micotitre plate and the absorbance 
read using a spectrophotometer (Bio-tek μQuant) at 532nm. The mean absorbance was divided 

























2.5. Protein expression – western blot  
2.5.1. Introduction  
Western blot is used to detect the presence of a protein of interest from a homogenous mixture 
of proteins extracted from cells. This proceedure relies on the separation of proteins according 
to their size, transfer of these proteins to a solid support, detection of the protein of interest 
using the appropriate anti-body and visualisation using chemiluminescence.  
2.5.1.1. Sample preparation  
Sample preparation involves lysis of cells to release proteins and quantification. This processes 
are carried out on ice to prevent degradation of the protein of interest. The samples must be 
quantified and standardised to ensure that protein concentration is sufficient to carry out the 
assay and to compare protein expression in each sample. The bicinchoninic acid (BCA) assay is 
a commonly used method to quantify total  protein in a sample. The principle of this assay relies 
on the formation of Cu2+- protein complex under alkaline conditions and subsequent reduction 
of  Cu2+ to Cu1+. The protein present is directly proportional to this reduction. BCA forms a 
violet complex with Cu1+ under alkaline conditions therefore provides a basis to monitor the 
reduction of Cu2+ by proteins. The BCA-Cu2+ complex is a relatively stable chromophore that 
absorbs at 562 nm (Figure 2.5) (Sapan et al., 1999).   
Once samples are standardised they are diluted in Laemmli buffer (contains glycerol - samples 
sink easily into the wells of the gel, bromophenol blue - a tracking dye which indicates how far 
the separation has progressed, β-mercaptoethanol – reduce disulphide bridges of proteins 
allowing them to unfold and SDS –neutralizes protein charges) so that they can be 







































Figure 2.5: Principle of the BCA assay used to quantify protein concentration (prepared by 
author).  
2.5.1.2. Separation of proteins  
Proteins are separated by size using sodium dodecyl sulfate polyacrylamide gel electrophoresis     
(SDS-PAGE). Since samples are denatured by the Laemmli buffer containing SDS the protein is 
uniformly charged (negative charge) and migrates toward the positive electrode through the gel. 
Since both the charge and tertiary structure of the proteins have been removed the proteins 
separate according to size through the polyacrylamide gel (Figure 2.6) (Healthcare, 2011).   
Polyacrylamide gels are inert with a cross-linked structure this enables it to retard the migration 
of larger molecules allowing smaller molecules to pass through the gel at a faster rate. The gel 
consists of two sections – resolving gel and stacking gel. The resolving gel is cast first and has a 
high concentration of acrylamide, this is important for separating proteins by size. The stacking 














Figure 2.6: separation of proteins according to size (prepared by author). 
2.5.1.3. Transfer of proteins to solid support  
On completion of the separation of proteins, the next step is to transfer the proteins from the gel 
to a solid support membrane (Figure 2.7), usually made of an inert substance, like nitrocellulose. 
The proteins transferred from the gels are immobilized at their corresponding migratory 













Figure 2.7: Transfer of proteins from gel to membrane. The gel is placed in contact with the 
membrane and the proteins migrate toward the positively charged anode in an electric field 




2.5.1.4. Immuno-blotting  
After transfer the protein of interest is detected using a specific antibody. A non-labelled 
primary anti-body is directed against the protein of interest and a species specific, labelled 
secondary antibody is directed against the primary anti-body. This secondary anti-body serves 
as a carrier of the label and is involved in signal amplification, since in theory many secondary 
anti-bodies can simultaneously bind to a single primary anti-body. The secondary anti-body is 
conjugated with horseradish peroxidase (HRP). In the presence of H2O2, HRP oxidises luminol 
to generate light (Figure 2.8). The intensity of the light emitted is directly proportional to the 




















Figure 2.8: Signal emission as a result of anti-body antigen interactions.  
 
2.5.1.5. Determining densitometry for analysis 
Detection of signals using a camera based imager results in one or more visible protein bands on 
the membrane image. The molecular weight of the protein can be determined by comparing it to 
the molecular weight marker and the quantity of protein can be determined as this is related to 
band intensity (Healthcare, 2011).  
To quantitate protein levels of the protein of interest normalisation to an internal reference such 




proteins that maintain cell viability. The use of these proteins minimises protein loading errors 
and varying protein concentrations between each well from affecting overall results (Healthcare, 
2011). The protein of interest is then quantified in relation to the housekeeping protein to 
determine relative band density. 
2.5.2. Protocol  
Western blot was run to determine protein expression of SIRT3, LON, Nrf2, PGC-1α, p-CREB, 
NRF1 and HSP70. Crude protein of control, FA and NAM treated cells was isolated using 
CytobusterTM (Novagen, San Diego, CA, USA) supplemented with phosphatase and protease 
inhibitors (Roche, Mannheim, Germany, 05892791001and 04906837001, respectively). 
Cytobuster (200µl) was added to flasks and incubated on ice for 10 minutes before being 
mechanically lysed. Cell lysates were decanted into 1.5 ml tubes and centrifuged (12,000xg, 10 
minutes) to obtain crude protein. The BCA assay was used to quantify protein which was 
standardized to 1.5 mg/ml.  
Samples were prepared in Laemmli buffer (dH2O, 0.5M Tris-HCl (pH 6.8), glycerol, 10% SDS, 
β-mercaptoethanol, 1% bromophenol blue])and electrophoresed (150V, 1 hour) in sodium-
dodecyl-sulfate polyacrylamide gels (4% stacking, 10% resolving) using BioRad compact 
power supply. Protein was then transferred onto nitrocellulose membranes using the Trans-
Blot® Turbo Transfer system (BioRad) (400mA, 45 minutes). Membranes were then blocked 
with 5% non-fat dry milk (NFDM) made up in Tris-buffer saline (TTBS) [0.5% Tween20, 
dH2O, KCL, Tris, NaCl, pH 7.4] for one hour at RT. Membranes were then immune probed 
with primary antibody (1:1000 dilution in 5% NFDM) against Nrf2 (ab31163, Abcam), PGC-1α 
(ab72230, Abcam), SIRT3 (ab86671, Abcam),phospho- CREB (9191, Cell Signaling 
Technology), HSP70 (4876, Cell Signaling Technology), NRF1 (12381, Cell Signaling 
Technology) and LONP1 (HPA002192, Sigma- Aldrich, St Louis, MO) for 1 hour at RT on a 
shaker then overnight at 4oC. Membranes were washed with TTBS (5 times, 10 minutes) and 
then incubated with secondary antibody conjugated to HRP [goat anti-mouse (31800); goat anti-
rabbit (ab6112) 1:10 000 in 1% BSA] for 1 h at RT on shaker. Membranes were then washed 
with TTBS (5 times, 10 minutes). Protein bands were visualized using Clarity Western ECL 
Substrate (BioRad) detection reagent. Images were captured using gel documentation system 
Alliance 2.7 (UViTech, Cambridge, UK). UViTech Alliance Analysis software was used to 
analyse protein expression.  
Membranes were stripped with 5% hydrogen peroxide, incubated in blocking solution (5% 




house-keeping protein, β-actin (Sigma). The relative band intensity was normalised against β-
Actin. Results were expressed as Relative band density (RBD).  
2.6. Gene expression – Quantitative polymerase chain reaction  
2.6.1. Introduction 
Polymerase chain reaction (PCR) is a powerful and simple tool used to amplify a specific DNA 
sequence in vitro from a template strand. Two oligonucleotide primers complementary to the 
sites flanking the target region are chemically synthesised. These primers attach to each of the 
DNA template strand at the 3‟ ends. The enzyme DNA polymerase then incorporates 
deoxynucleotide triphosphates (dNTPs) to the 3‟ ends of the primers in a stepwise manner. 
The PCR is performed in a thermocycler where it undergoes repetitive cycling of three 
incubation steps at different temperatures (Figure 2.9). The three steps include: 
1. Denaturation: Double stranded (ds) DNA is denatured by heat (900C) to form single 
stranded (ss) DNA. 
2. Annealing: Complementary primers to the target sequence are annealed to the template 
DNA at a low temperature (55OC).  
3. Extension: The annealed primers are extended by a DNA polymerase                                        
(Taq DNA polymerase, 720C). The target copy is amplified upon each cycle. This 








































Figure 2.9: Steps of the PCR cycle leading up to DNA amplification (prepared by author). 
 
 
Conventional PCR allows for the successful amplification of DNA, however accurate 
quantification is a limitation of this technique. Quantitative PCR, a variation of the original PCR 
process is used to determine the amount of product produced (i.e. the expression of target gene 
in a sample).  
RNA is isolated from cells and reverse transcribed to ss complementary (c) DNA. This cDNA is 
used as the starting material for q-PCR. The q-PCR undergoes the same cycling steps as the 
conventional PCR. Quantification of DNA is made possible by adding a DNA-binding dye 
called SYBR Green to the reaction that can be detected after excitation. This dye binds to 






















with the gene of interest, samples are analysed for expression of a house keeping gene, and the 











Figure 2.10: Fluorescence increases dramatically when dye molecules bind to dsDNA 
(prepared by author) 
2.6.2. Protocol  
RNA was isolated from control, FA and NAM treated flasks with Qiazol reagent (Qiagen, 
Hilden, Germany). Briefly, 500 µl Trizol was added to 500 µl cells (2.5 X 106 in 0.1 M 
PBS) and incubated for 1h at -800C. Chloroform (100 µl) was then added and centrifuged 
(12,000Xg, 15 min, 40C) followed by the addition of isopropanol (250 µl, 1 h, -800C) before 
centrifugation (12,000Xg, 20 min, 40C). Samples were then washed with 500 µl ethanol 
(75%) and centrifuged (7,400Xg, 15 min, 40C). Following removal of ethanol, RNA pellets 
were re-suspended in 15 µl of nuclease-free water, quantified (Nanodrop2000) and 
standardised (1,000 ng/ml). A 20 µl reaction volume containing 1 µl RNA template, 4 µl 5X 
iScript™ reaction mix, 1 µl iScript reverse transcriptase and nuclease free water was used to 
synthesize cDNA (iScript™ cDNA Synthesis kit, BioRad; catalog no 107-8890). 
Thermocycler conditions were 250C for 5 min, 420C for 30 min, 85 0C for 5 min and a final 









Gene expression of SIRT3 was assessed (Sense 5‟-CGGCTCTACACGCAGAACATC-3; 
Anti-sense 3-CAGCGGCTCCCCAAAGAACAC-5‟) using the iQ™ SYBR® Green PCR kit 
(Bio-Rad; 170-880) and carried out using CFX Touch™Real Time PCR Detection System 
(Bio-Rad, Hercules, CA, USA). The PCR was initiated with the following thermocycler 
profile: An initial denaturation for 8min at 950C followed by 39 cycles of   950C, 
denaturation for 15 sec, annealing for 1min at 500C, and extension of 720C for 30 sec. A 
final extension at 700C was performed for 30 sec. Each measurement was done in triplicate 
and normalized against β-actin which was run under the same conditions and used as the 
housekeeping gene. Data was analysed using the method described by Livak and 
Schmittgen (2001) (Livak and Schmittgen, 2001) and represented as fold change relative to 
the housekeeping gene, β-actin (Sense5‟-TGACGGGTCACCCACACTGTGCCCAT-3‟, 
Anti-sense5‟CTAGAAGCATTTGCGGTGGACGATGGAGGG-3‟).  Experiments were run 
in triplicate.  
2.7. Assessment of caspase activity 
2.7.1. Introduction  
The Caspase Glo® 9 Assay and Caspase Glo® 3/7 Assay are homogenous luminescent assays 
that measure caspase 9 and caspase 3/7 activity respectively. Caspase 9 is an initiator caspase 
and plays a pivotal role in the intrinsic apoptotic pathway. Caspase 3/7 play key effector roles in 
the apoptotic programme and are responsible for the many biochemical characteristics 
associated with this process. These assays provide a luminogenic caspase 9 and 3/7 substrate in 
a buffer system that has been optimized for cell lysis, caspase and luciferase activity. The above 
mentioned caspases cleave the substrate and generate a luminescent signal as a result of the 
luciferase reaction (Figure 2.11). Caspase activity is proportional to the luminescent signal.  
2.7.2 Protocol 
The Caspase Glo® 9 Assay and Caspase Glo® 3/7 Assay kits (Promega, Madison, USA) were 
used to detect caspase activity. For both assays the same procedure was followed: FA treated 
and untreated cells were seeded into an opaque 96-well polystyrene plate in triplicate (20,000 
cells/well in triplicate).  The Caspase Glo® 9 and Caspase Glo® 3/7 reagents were prepared 
according to the manufacturer‟s instructions and 50µl of the reagent was added to the samples. 
The samples were then incubated in the dark at room temperature (30 mins). Following 
incubation period luminescence was detected and quantified using a Modulus™ microplate 
luminometer (Turner Biosystems, Sunnyvale, USA). The data was expressed as mean relative 














Figure 2.11: Schematic of the caspase activity assay (prepared by author).  
 
2.8. Cytotoxicity – lactate dehydrogenase assay (LDH) assay  
2.8.1. Introduction  
Cell death can be evaluated by assays assessing cell membrane damage. Such assays are often 
based on the activity of cytoplasmic enzymes released by damaged cells. The amount of enzyme 
activity detected correlates to the extent of membrane damage. LDH is a stable cytoplasmic 
enzyme present in all cells and is rapidly released into culture supernatant upon loss of 
membrane integrity.  
The LDH activity is measured by an enzymatic test. In the first step NAD+ is reduced to 
NADH/H+ by the conversion of lactate to pyruvate catalysed by LDH. In the second step 
diaphorase (catalyst) transfers H/H+ from NADH/H+ to the tetrazolium salt INT which is 
reduced to formazan (Figure 2.12).  The release of enzyme and its activity is proportional to cell 





The LDH cytotoxicity detection kit (Roche, Mannheim, Germany) was used to measure cell 
death/membrane damage. To measure LDH activity, supernatant (100μl) was transferred into a 
96-well microtitre plate in triplicate. Thereafter, substrate mixture (100μl) containing catalyst 
(diaphorase/NAD+) and dye solution (INT/sodium lactate) was added to the supernatant and 
allowed to react at RT for 25min. Optical density was measured spectrophotometrically at 





















Figure 2.12: Reactions of the LDH cytotoxicity assay (prepared by author). 
 
2.9 DNA damage – Single Cell Gel Electrophoresis (SCGE)  
2.9.1 Introduction  
The SCGE is a rapid and sensitive method for determining the extent of DNA damage in 
individual cells. For this assay cells are embedded in an agarose gel and lysed in a high salt 
detergent solution. This results in release of DNA that when subjected to electrophoresis under 
alkali conditions migrates toward the anode. A stain is used to visualise the extent of DNA 
strand breaks.  
Lactate Pyruvate 








The images produced by this assay appear as “comets” with a head and a tail that can be 
measured. The head contains intact DNA while the tail contains migrating fragments of 
damaged DNA. These DNA fragments are smaller in size therefore migrate further through the 
gel than intact DNA (Figure 2.13).  
2.9.2 Protocol 
The SCGE assay was used to determine DNA fragmentation in the FA treated cells. Three slides 
per sample were prepared. A volume of 700µl of 2% low melting point agarose (LMPA) was 
pipetted toward the frosted end of a 76x26mm microscope slide. A 60x20mm coverslip was 
then placed over the molten agarose. It is paramount that the formation of air bubbles be 
avoided during this step. This first layer is needed to provide anchorage for subsequent layers of 
gel.  
The cover slip was removed carefully using a needle point. A volume of 25µl cell suspension 
with approximately 20 000 cells from relevant treatments were transferred into a 1.5ml 
microcentrifuge tube along with 175µlof 1% LMPA at 370C and 1µl GR red (staining solution). 
The resulting solution was stirred and immediately pipetted onto the first solid layer. The slides 
were then covered with cover slips and maintained at 40C for ten mins. This second layer 
provides a meshwork in which the cells remain encapsulated and immobile.  
The cover slip was once again removed and a third layer of gel was laid down. 200µl of 1% 
LMPA at 370C was pipetted onto the second layer. Cover slips were placed on each of the slides 
and the final layer was allowed to solidify at 40C for ten mins.  
Once the gel had solidified the cover slips were removed and submerged in freshly prepared 
cold lysing solution. Slides were then incubated at 40C for one hour and protected from light. 
The lysing solution (2.5M NaCl, 100mM EDTA, 1% Triton X-100, 10mM Tris (pH 10) and 
10% DMSO) must be chilled so as to maintain the stability of the agarose gel layers. The lysis 
step is required to remove cell membranes, nucleoplasm and cytoplasm as well as dissolving 
nucleosomes since the solution is a hypertonic detergent. 
After the elapsed incubation time the slides were removed from the lysing solution. Slides were 
then placed side-by-side into the electrophoresis tank with the frosted end closest to the cathode. 
The tank was filled with the prepared electrophoresis buffer (300mM NaOH, 1mM Na2EDTA, 
pH 13) to a level approximately 20mm above the slides. The cells were then allowed to 
equilibrate for 20 minutes in the alkaline electrophoretic solution. This equilibration step is 




Furthermore the high alkali concentration improves the resolving power of the assay without 
affecting sensitivity.  
Following incubation the tank was sealed and a current of 300mA (25V) was applied 35min at 
RT using a Bio-Rad compact power supplier. This step is required to cause fragments of DNA 
to migrate toward the anode if there are breaks in the DNA. The DNA fragments are localized at 
the tail portion whilst the intact DNA is located at the head.  
After electrophoresis the buffer was removed and the slides were washed three times with 
neutralization buffer (0.4M Tris, pH 7.4) for 5 min each to remove detergents and neutralize 
excess alkali. The slides were viewed using a fluorescent microscope (Olympus IXSI inverted 
microscope) using filter 4 (510-560 nm excitation and 590 nm emission filters).  Images of 50 
cells were taken per treatment, these were analysed Soft imaging system (Life Science – 












Figure 2.13: Principle of the SCGE assay (prepared by author) 
 
2.10. Statistical analyses  
Data was analysed using GraphPad prism V5.0 software (GraphPad Software Inc., La Jolla, 
USA.) Data was considered to be statistically significant with a p value < 0.05. Unpaired t-test 
with Welch correction (data reported as mean ± standard deviation) or the one-way analysis of 
variance (ANOVA) followed by a Bonferroni test for multiple group comparison (data is 
presented as 95% CI) was used to determine statistical significance.  
DNA migration 
Apoptotic cell 




The unpaired t-test is employed to compare two groups of data (control vs. treatment) when 
observations are not equal and the data is continuous yet randomly distributed (Barile, 2013). 
Welch‟s correction assumes that both data sets are sampled from Gaussian populations but does 
not assume that these data sets have an equal standard deviation (Prism, 2016). 
The ANOVA test compares the total variation present in more than two groups of data sets 
(Barile, 2013).  The Bonferonni test compares every pair of means but are selected baed on 
experimental design. When comparing multiple pairs of grouped data at once the individual p 
value can not be determined in the normal way, instead a significance level is set and 

















CHAPTER 3: RESULTS 
3.1. Mitochondrial Output  
To determine the effect of FA on mitochondrial output, cell viability and intracellular ATP 
levels were assessed.  
3.1.1. Cell viability  
 A dose response curve was obtained using serially diluted concentrations of FA (0-500µg/ml) 
in HepG2 cells over 24h. The curve showed that FA decreased metabolic activity in a dose 
dependent manner; 104µg/ml FA caused a 50% inhibition (IC50) of metabolic activity and this 



















Figure 3.1: A dose dependent decline in metabolic activity following treatment with varying 
concentrations (0, 25, 50, 100, 250, 350, 500 µg/ml) of FA. 
 
3.1.2. Intracellular ATP levels 
Intracellular ATP level was measured using a luminometric assay. Figure 3.2 shows that FA 
caused a significant (p = 0.0062) decrease in ATP levels (0.815 ± 0.0682 × 106 RLU) when 




























Figure 3.2: Intracellular ATP levels were significantly depleted (**p=0.0062) in FA treated 
cells. Results are presented as mean ± standard deviation. 
 
3.2. Oxidative stress and detoxification  
3.2.1. Oxidative stress 
Lipid peroxidation was used as a measure of oxidative stress. MDA levels were significantly 
increased in FA treated cells when compared to control cells (P = 0.0002; 95% CI, -14.02×103 
to -6.644 ×10-3). Higher MDA levels were also observed in FA treated cells relative to NAM 
treated cells (p = 0.0002; 95% CI: 5.978 × 10-3 to 13.36 × 10-3). NAM treatment did not exhibit 




































Figure 3.3: FA induced oxidative stress as indicated by elevated MDA levels (***p = 0.0002) 
when compared to NAM and the untreated control. Results are expressed as mean ± standard 
deviation. 
3.2.2. Phase 2 detoxification 
Increased oxidative stress by FA may interfere with cellular anti-oxidant systems such as Nrf2 
expression. FA significantly increased Nrf2 expression (western blots) when compared to both 
untreated controls (p < 0.0014; untreated vs. FA, 95% CI, 3.058 ×10-2 RBD to -0.367 × 10-2 
RBD; FA vs. NAM, 95% CI 1.493 × 10-2 RBD to 3.9× 10 -2 RBD) but no significant changes 


































Figure 3.4: The regulator phase II detoxification responses (nrf-2) was found to be significantly 
elevated (*/**p < 0.0014) in FA treated cells when compared to NAM and the untreated cells. 
3.3. Mitochondrial stress 
3.3.1. Sirtuin 3 
Sirtuin 3 is a key regulator of mitochondrial function and stress responses. Changes to protein 
and gene expression of SIRT3 in FA and NAM (positive control) treated cells relative to 
untreated cells were examined. Since NAM is a known inhibitor of SIRT3 activity, the activity 
of SIRT3 in response to FA can be better understood.  
Following exposure to FA, a significant decrease in SIRT3 protein expression in comparison to 
both sets of control cells (p = 0.0012; untreated vs. FA, 95% CI, 0.2884 × 10 -3   RBD to    
0.7275 × 10 -3  RBD; FA vs. NAM, 95% CI -0.5893 X 10 -3  RBD to -0. 1502 × 10 -3  RBD) was 
observed (Figure 3.5A).  
To validate the reduced expression of SIRT3 at the protein level SIRT3 gene expression was 
investigated with qPCR. These results show gene expression to be significantly down-regulated 
in response to FA but not NAM when compared to untreated cells (Figure 3.5B) (p = 0.0007; 

























Figure 3.5: FA significantly decreased both SIRT3 protein (A, **: p = 0.0012) and mRNA                                                    
(B, ***/**p = 0.0007) expression levels 
3.3.2. Lon Protease  
The down-regulation of SIRT3 has implications for mitochondrial stress responses. Protein 
expression of LON, a key mitochondrial stress response protein was measured. FA significantly 
decreased expression of LON in the untreated control (p = 0.0044; untreated vs. FA, 95% CI, 
0.1997 RBD to 1.287 RBD; untreated vs. NAM, 95% CI 0.4179 RBD to 1.411 RBD). The 






























Figure 3.6: LON protein expression was significantly down-regulated (**: p = 0.0044) in cells 
treated with FA and NAM.  
3.4. Mitochondrial biogenesis  
Since both SIRT3 and LON are involved in mitochondrial biogenesis, the effects of FA in this 
process were further investigated.  
3.4.1. Peroxisome proliferator-activated receptor γ co-activator α (PGC-1α) 
The effect of FA on PGC-1α protein expression, the master regulator of mitochondrial 
biogenesis (Ventura-Clapier et al., 2008) was determined and is shown in figure 3.7. 
Significantly lower levels of PGC1-α protein expression was observed in FA and NAM treated 
cells when compared to the untreated control (p = 0.0005; untreated vs. FA, 95% CI, 0.09168 
RBD to 0.2127 RBD; untreated vs. NAM, 95% CI 0.09206 RBD to 0.2274 RBD). However no 






































Figure 3.7: FA significantly decreased the expression of PGC-1α (***: p = 0.0005). 
 
 
3.4.2. Phosphorylated cAMP response element binding protein (p-CREB).   
The expression of the mitochondrial biogenesis regulatory protein p-CREB was examined and 
found to be significantly decreased in response to FA and NAM stimulation (p = 0.0008; 
untreated vs. FA, 95% CI, 0.361 ×10 -3 RBD to 1.362 10 × -3  RBD; untreated vs. NAM, 95% CI   






























Figure 3.8: The expression of p-CREB was significantly down-regulated in response to both 
FA and NAM treatment (***/**: p = 0.0008) 
 
3.4.3. Nuclear respiratory factor 1 (NRF-1) 
Mitochondrial biogenesis is regulated at the transcriptional level by NRF1. As seen in figure 3.9 
both FA and NAM induced significant decreases in NRF1 expression in comparison to 
untreated cells (p = 0.0004; untreated vs. FA, 95% CI, 0.1124 RBD to 0.2121 RBD; untreated 
vs. NAM, 95% CI 0.1177 RBD to 0.2270 RBD) but no significant changes were noted between 





































Figure 3.9: Both the FA and NAM stimulated cells exhibited significantly decreased protein 
expression of NRF-1 when compared to untreated cells (***: p = 0.0004)   
 
3.4.4. Heat shock protein 70 (HSP70) 
The chaperone protein HSP70 expression was determined. FA was seen to significantly 
decrease protein expression of HSP70 when compared to untreated and NAM stimulated cells 
(P = 0.0102; untreated vs. FA, 95% CI, 0.5672 RBD to 3.234 RBD; FA vs. NAM, 95% CI 



































Figure 3.10: The expression of HSP70 was significantly decreased in response to FA 
stimulation when compared to both NAM and the untreated control cells (*p = 0.0102). 
3.5. Cell damage and death 
Since both mitochondrial and oxidative stresses culminate in cell damage/death the effect of FA 
on cell membrane integrity/cytotoxicity and caspase activity were investigated.  
3.5.1. Membrane integrity and cytotoxicity 
Seeing that MDA (by-product of lipid peroxidation) levels were increased we investigated the 
effect of FA on cell membrane integrity. FA induced significant cell membrane damage when 
compared to control cells as measured by increased LDH activity in FA treated cells (p<0.0001, 
2.902 ± 0.1385 vs. 0.8328 ± 0.06286) as shown in figure 3.11. The elevated LDH level is also 































Figure 3.11: FA caused significant membrane damage and is cytoxic to the HepG2 cell line as 
indicated by the LDH assay (***p<0.0001).  
3.5.2. Caspase activity 
The activities of caspase 9, the intrinsic apoptotic initiator and the executioner caspases 3 and 7 
were measured. These results, presented in table 3, show FA significantly increased (p= 0.0032) 
the activity of caspases 3 and 7 when compared to control cells (7.482 ± 0.4973  vs. 24.040 ± 
1.551). However no significant difference was observed in caspase 9 activity. 
Table 2 Caspase activity in FA treated cells.  
Caspase Mean ± SD (RLU X 103) p-value 
Control FA 
    
9 175.6 ± 9.423 166.30 ± 14.710 0.3340 
3/7 7.482 ± 0.4973 24.040 ± 1.551 0.0032** 
    





CHAPTER 4: DISCUSSION 
FA is produced by Fusarium spp, a ubiquitous soil fungus, and contaminates many agricultural 
products (Bacon et al., 1996), to date the belief was that it possessed low to mild toxicity . The 
liver is susceptible to toxic insult (Fenton, 2002, Wang and Ng, 1999). Hepatocytes are densely 
populated with mitochondria which serve as integrators for several metabolic pathways and 
regulators of hepatocyte survival. Hepatocyte damage is strongly associated with mitochondrial 
dysfunction coupled with increased ROS production (Esposti et al., 2012).  
Previous studies have implicated ROS generation as a  major contributor to FA induced toxicity 
(Hirai et al., 2005, Iwahashi et al., 1999, Jiao et al., 2014) whilst other studies showed FA 
chelation as a toxic mechanism (Ruda et al., 2006, Stack et al., 2004). The molecular 
mechanisms of FA toxicity, however, are not fully elucidated. SIRT3 regulates many aspects of 
mitochondrial function including ATP generation and stress responses (Chen et al., 2014). 
SIRT3 ideally functions as a mitochondrial fidelity protein and a loss of its function can result in 
cellular damage and eventual death. 
The results show that FA decreased cell viability in a dose dependent manner, with a drastic 
decrease at higher concentrations (Figure 3.1). The MTT assay measures cell viability based on 
the generation of reducing equivalents by metabolically active cells (Nikzad et al., 2014). 
Telles-Pupilin et al. (1998) showed that FA impedes oxidative reactions of the Kreb‟s cycle by 
inhibiting α-ketoglutarate dehydrogenase and succinate dehydrogenase (Telles-Pupulin et al., 
1998); α-ketoglutarate dehydrogenase regulates metabolic flux via the Kreb‟s cycle and 
catalyzes the conversion of α-ketoglutarate to succinyl-CoA producing NADH and directly 
provides electrons for the respiratory chain. Succinate dehydrogenase oxidizes succinate to 
fumarate producing FADH2 and transfers electrons from succinate to ubiquinone thus playing a 
role in the Kreb‟s cycle and ETC (Champe et al., 2005). These results seem to be in agreement 
with studies that show FA interferes with reducing equivalent metabolism.  
SIRT3 down-regulation at both the protein and gene levels (Figure 3.5A and 3.5B) shows that 
FA may selectively target the mitochondrion. Also, FA is a weak acid and this may also explain 
its mitochondrial toxicity (weak acids disrupt the hydrogen gradient across the mitochondrial 
membrane and decreases ATP production). The decreased SIRT3 protein expression can be 
attributed to its decreased gene transcript levels. It is also possible that FA, an efficient chelator 
of zinc (Stack et al., 2004), directly down regulated SIRT3 protein expression. SIRT3 contains a 
conserved enzymatic core with two domains, including a large Rossmann fold domain that 




atom (Nogueiras et al., 2012). FA may have caused loss of functional stability of SIRT3 through 
removal of the zinc ion.  
FA severely depleted intracellular ATP levels (Figure 3.2). Ahn et al (2008) showed decreased 
respiration and ATP levels in SIRT3 double knock-out mice livers (Ahn et al., 2008), and is in 
agreement with the human in vitro model data in Figure 3.2. SIRT3 targets NADH 
dehydrogenase and succinate dehydrogenase and stimulates their activity (Finley et al., 2011, 
Chen et al., 2014). FA is structurally similar to NAM and may inhibit SIRT3 activity through 
competitive binding at the NAD+ site. Furthermore, these complexes contain iron-sulphur 
clusters (Champe et al., 2005, Atamna et al., 2002); FA can chelate iron in vitro (Hirai et al., 
2005), and this would prevent the transfer of electrons in the ETC.    
Furthermore, it was shown that FA directly suppressed the ETC by inhibiting ATP synthase 
activity (Telles-Pupulin et al., 1998). Thus FA may directly or indirectly inhibit mitochondrial 
enzymes as well as reducing equivalent metabolism and decrease ATP synthesis.  
FA significantly elevated levels of MDA, a byproduct of lipid peroxidation and marker of 
oxidative stress (Figure 3.3). This is in agreement with Jiao et al (2014) (Jiao et al, 2014). 
Although ROS is damaging to a variety of cellular macro-molecules, membrane lipids are 
especially sensitive to free radicals due to the presence of PUFAs (Tretter and Adam-Vizi, 
2005). The inhibition of the ETC by FA is a likely cause of the highly oxidative environment. It 
was shown that inhibition of the ETC, particularly at complex I and II leads to the increased 
generation of ROS (Chen et al., 2007). FA itself is thought to induce oxidative stress through 
chelation of iron and enhancement of the Fenton reaction (Hirai et al., 2005, Iwahashi et al., 
1999). The nitrogen atom in the pyridine ring and the oxygen atom in the carboxyl group, may 
act as a chelator and enhance the Fenton reaction leading to formation of the hydroxyl radical 
(Iwahashi et al., 1999).  
Induction of the phase 2 response is an important cellular defense to oxidative stress and is 
dependent on the release of Nrf2 from its repressor KEAP-1, a zinc thiol protein. Zinc is bound 
to reactive cysteine thiols of Keap1 and is displaced by electrophiles. Release of zinc alters the 
conformation of Keap1 thereby allowing translocation of Nrf2 to the nucleus (Dinkova-Kostova 
et al., 2005). FA significantly increased in Nrf2 expression (Figure 3.4). However, given that 
KEAP-1 is a zinc thiol protein it may be possible that FA chelates this ion and enhances the 
release of Nrf2. Despite elevated Nrf2 levels, the increased oxidative stress in the HepG2 cells 
still persisted. This may be due to the chelation of zinc, a critical ion involved in the activation 




SIRT3 acts to dampen oxidative stress through enhanced expression and activity of SOD2 (Tao 
et al., 2010, Qiu et al., 2010). SIRT3 expression is normally up-regulated by oxidative stress 
(Flick and Lüscher, 2012); however our results show that FA decreased its expression at the 
gene level (Figure 3.5B).  Kong et al. (2010) showed that PGC-1α stimulated SIRT3 expression 
at the gene and protein levels (Kong et al., 2010) via CREB phosphorylation (Flick and Lüscher, 
2012) and SIRT3 in turn up-regulated PGC-1α expression –these proteins are regulated by a 
positive feedback loop (Chen et al., 2014). The results support this as FA is shown to disrupt 
this feedback loop by down regulating SIRT3, PGC-1α and p-CREB (Figure 3.5A, 3.5B, 3.7, 
3.8).  Although no direct regulation of PGC-1α by SIRT3 has been reported, a study showed 
that SIRT3 expression is required for the induction of oxidative responses by PGC-1α (Kong et 
al., 2010). Interestingly inhibition of SIRT3 by NAM resulted in similar reductions to PGC-1α 
and p-CREB protein expression when compared to FA treated cells, thus supporting the 
hypothesis that FA can dysregulate SIRT3 activity through competitive inhibition.  
Despite FA and NAM inhibiting SIRT3 and resulting in similar reductions to PGC-1α protein 
expression, no significant elevation in MDA levels was observed in NAM treated cells as 
compared to untreated controls. There was also no difference in the expression of Nrf2 by 
NAM. These results are supported by a study in SIRT3 knock-out mouse embryonic fibroblasts 
that showed oxidative stress to only be significantly elevated upon induction of cellular stress 
(Kim et al., 2010).  
The removal of oxidatively damaged proteins via proteolytic degradation is an important cell 
defense to high oxidative stress. Oxidized mitochondrial proteins must be removed rapidly to 
prevent their aggregation, cross linking and toxicity. LON, an ATP dependent protease, 
catalyzes the degradation of oxidatively damaged proteins in the mitochondrial matrix (Bota et 
al., 2005 ). LON expression was decreased after treatment with both FA and NAM (Figure 3.6). 
Given that Nrf2 expression was up-regulated and SIRT3 expression down regulated by FA, it is 
likely that FA induced LON disruption at the post-translational level. This is supported by 
inhibition of SIRT3 with NAM showing similar reductions in LON expression.  Furthermore 
the depletion of ATP by FA will prevent catalytic activity of LON inhibiting proteolytic 
degradation of oxidized proteins. FA induced mitochondrial stress in HepG2 cells is further 
aggravated by loss of LON function.  
Since FA induced both oxidative and mitochondrial stress, we then determined its effect on 
mitochondrial biogenesis. Increased mitochondrial biogenesis aids cells to prevent 
mitochondrial lesions and maintain mitochondrial integrity (Esposti et al., 2012). PGC-1α is 




transcription factor) activates the expression of oxidative phosphorylation components and the 
expression of Tfam resulting in increased expression of nuclear mitochondrial genes and 
mitochondrial DNA replication (Piantadosi and Suliman, 2006). A decrease in NRF1 expression 
by FA was noted (Figure 3.9). Kong et al (2010) found that inhibition of SIRT3 expression 
diminished the PGC-1α induction of mitochondrial biogenesis. They proposed that NRF1 is a 
substrate of SIRT3 however further studies are required to determine the molecular mechanism 
by which SIRT3 controls mitochondrial biogenesis (Kong et al., 2010).  
Most genes encoding mitochondrial proteins are located in the nucleus rather than in the 
mitochondrial genome, these proteins must be imported into the mitochondria. This involves 
complex folding and assembly processes to ensure proper enzyme activity (Voos, 2013).  
HSP70 is involved in mitochondrial protein homeostasis and  by mediating translocation and 
folding reactions (Voos, 2013). The results show decreased expression of HSP70 by FA                  
(Figure 3.10). HSP70 co-ordinates two calcium ions one of which contributes to protein stability 
while the other is needed to carry out ATP hydrolysis (Sriram et al., 1997), thus FA may affect 
both stability and activity of HSP70 through chelation of calcium. Additionally FA mediated 
depletion of ATP will impede folding reactions of HSP70 since ATP hydrolysis is coupled with 
its molecular chaperone function (Voos, 2013). LON can also act as a chaperone, independent 
of its proteolytic activity and promote the assembly of cytochrome c oxidase subunits. Thus 
down regulation of LON results in impaired respiratory function (Bota et al., 2005 ). Gibellini 
and colleagues (2014) showed that decreased LON levels impairs mitochondrial function 
(Gibellini et al., 2014b).  
Further, this group also showed activation of executioner caspase 3 and apoptotic cell death as a 
result of LON down-regulation (Gibellini et al., 2014b). Our results are in agreement as we also 
show increased activity of caspase 3 (Table 2), a marker of apoptosis, involved in the execution 
of this process. Apoptosis may be a result of proteolytic defects of LON resulting in 
accumulation of oxidized proteins while loss of chaperone function impairs mitochondrial 
respiration.  
Given that mitochondrial stress was induced by FA it seemed logical to assume that the 
enhanced activity of caspase 3/7 would be attributed to the intrinsic apoptotic pathway. 
However, the data presented in table 2 suggest that caspase 9 is not a good candidate for the up-
stream activation of caspase 3/7 since this initiator caspase is slightly decreased in FA treated 
cells when compared to control cells. In the cytoplasm, cytochrome c binds to the APAf-1 and 




reaction cascade leading to the execution of apoptosis via caspase 3 activity (Dai et al., 2014). 
Seeing that cytochrome c is an iron metalloprotein and absolute requirement for caspase 9 
activity, the loss of iron from cytochrome c by FA mediated chelation can prevent the proper 
formation of the apoptosome leading to decreased activity of caspase 9. Furthermore, results 
have emerged providing evidence that Apaf-1 transforms ATP into ADP and is an ATPase and 
that ATP is essential for Apaf-1 binding to cytochrome c (Hu et al., 1999 , Chiarugi, 2005). 
Thus FA may prevent activation of caspase 9 by depletion of intracellular ATP.  
The IAP family of proteins selectively binds and inhibits caspases to prevent apoptosis. All 
IAPs contain 1–3 BIR domains, which are cysteine and histidine rich and can fold into 
functionally independent structures that bind zinc (Zuo et al., 2012 ). The XIAP is the most 
potent member of this family (Makhov et al., 2008). The BIR2 domain of XIAP can bind to the 
amino terminal end of the small subunit of caspase-7 causing its inhibition, while the linker 
region accounts entirely for the inhibition of caspase-3. The BIR3 domain directly binds to, and 
inhibits caspase-9 through an amino-terminal end created by caspase-9 self-cleavage. The BIR1 
domain displays no inhibitory activity. Essentially, the E3 ligase activity of the really interesting 
new gene (RING) finger domain allows XIAP to trigger ubiquitination of caspases 3 and 7, a 
process that represents one of the potential anti-apoptotic mechanisms of XIAP                                
(Zuo et al., 2012 ). Studies conducted on the effects of zinc chelators and the expression of 
XIAP reveal XIAP depletion by destabilization of this metalloprotein and subsequent activation 
of caspases upon zinc removal (Zuo et al., 2012 , Makhov et al., 2008). The loss of function of 
the RING finger domain may also lead to enhanced caspase activity since ubiquitination is no 
longer possible. Thus, FA being an efficient chelator of zinc can interfere with XIAP stability 
and ubitination function, allowing apoptosis to proceed uninhibited by this IAP family member 
enhancing cell death.   
Furthermore LON deficient cells switch to necrosis as a result of ATP depletion caused by 
mitochondrial defects.  LDH release was increased - an indication of increased necrotic cell 
death (Figure 3.11). Thus, while apoptosis may be initiated after FA treatment the switch to 
necrotic cell death may be as a result of depleted ATP.   
However, given that this leakage is a consequence of loss of cell membrane integrity, most 
likely caused by elevated oxidative stress, the role of the mitochondria in lipid synthesis cannot 
be dispelled. Indeed, experiments conducted by Schwer et al. (2006) clearly described a 





McGuirik et al (2013) showed that glutamine metabolism can be dysregulated by the decreased 
expression of PGC-1α. Their experiments revealed PGC-1α and ERRα regulate both the 
canonical citric acid cycle (forward) and the reductive carboxylation (reverse) fluxes by 
modulating glutamine flux through the Kreb‟s cycle; the latter can be used to support de novo 
lipogenesis reactions (McGuirk et al., 2013). Given that FA was shown to down-regulate SIRT3 
and PGC-1α expression suggests that FA not only affects mitochondrial output but can also 
contribute to the dysregulation of other mitochondrial processes such as fatty acid metabolism.   
The importance of fungi parasitizing agricultural produce is of concern due to their ability to 
produce mycotoxins. These toxins are often associated with disease states including 
tumorigenesis.  Mycotoxins found to be contaminating maize are a health risk since maize 
forms part of a staple diet for many South Africans. High risk groups include subsistence 
farmers and poor rural communities as these groups have low socio-economic status and food 
security is often compromised.   
An understanding of toxic mechanisms provides a basis between exposure and adverse health 
outcomes. Although some mycotoxins have been extensively studied and the pathways that give 
rise to their pathologies have been described, little is known about the effects of FA, particularly 
in human models. The results presented in this study describe the toxic mechanism of FA in a 
liver derived human cell line, providing evidence for hepatotoxicity that may aid in 
understanding and predicting the risks of FA exposure on the health of people and animals. 
Thus, these results will be important in food safety and may help raise awareness of FA toxicity 
as well as encourage good agricultural practises, both pre and post harvest , to limit the presence 
of this commonly neglected mycotoxin in maize. 
Previous studies have implicated mitochondrial dysfunction and excessive production of ROS 
as possible mechanisms of FA induced toxicity (Jiao et al., 2014, Telles-Pupulin et al., 1998). 
The data of this study points to FA mediated loss of SIRT3 leading to the aberrant regulation of 
the mitochondrial acetylome regulatory network and shows that mitochondrial function and 
biogenesis is seriously impaired by FA and oxidative stress is increased. This provides an 







CHAPTER 5: CONCLUSIONS 
5.1. Limitations of study  
In vitro studies entail subjecting cells to doses of a toxin. The objective of in vitro studies is to 
determine the potential influences of such toxins, and to isolate them from other types of 
influences. However, a major disadvantage is that cells are removed from their natural 
environment, thereby eliminating the interaction and protection mechanisms otherwise available 
from the donor organism. In order to improve this study the use of a primary hepatocyte cell 
model and an in vivo mouse model will go a long way in establishing a holistic response to FA.  
This study only made use of a 24 hour exposure period. Many proteins and stress pathways 
respond differently to toxins under acute and chronic conditions, therefore it would be 
interesting to determine the effects of FA in the HepG2 cell line after 6 hour and 48 hour 
exposure times to simulate acute and chronic exposures respectively.  
This study did not assess the morphological changes to mitochondria in response to FA. 
5.2. Conclusion 
Taken together data of this study show that mitochondrial function and biogenesis is seriously 
impaired by FA. The results discussed above suggest that loss of SIRT3 leads to the aberrant 
regulation of the mitochondrial acetylome regulatory network and results in cellular damage and 
death. Our results point to loss of SIRT3 in response to this mycotoxin as a possible mechanism 
for cytotoxicity in the HepG2 cell line.  
Oxidative stress responses such as mitochondrial protein quality control systems and proper 
regulation of biosynthetic processing in the mitochondria are essential for maintaining 
metabolic homeostasis and adaptation in cancer cells. Examination of cellular responses to 
mitochondrial stress and dysfunction after FA treatment provides useful information to unravel 
the molecular basis of this mycotoxins mechanism of action 
The poverty problem in South Africa is largely rural, with subsistence farming playing a huge 
role in supplementing impoverished communities (Machethe, 28-29 October 2004). Maize can 
be infected with a host of toxigenic fungi including species of Fusarium which produce 
Fusariotoxins. Given that maize is an important agricultural commodity, particularly in rural 
South Africa, this study has provided some answers to the mechanism of FA toxicity and its 




5.3. Future studies  
While the current in vitro study provided some answers to the molecular mechanisms involved 
in the mitochondrial dysfuntion in liver cells after treatment with FA it cannot provide a holistic 
response. Therefore, the use of a primary cell line along with an in vivo mouse model will 
enhance the findings of this study and add to the body of knowledge surrounding the toxic 
potential of this mycotoxin. It will also be worthwhile to look at different exposure time periods 
to determine the toxicity of FA under acute and chronic scenarios.   
Given that the liver is a key detoxifying organ it will be worth investigating the bio-
transformation of FA and its effects on the cytochrome system. The processing of FA in the 
liver will provide the information necessary to determine if any toxic metabolites are produced.  
This study also alluded to fatty acid/lipogenesis dysregulation by FA. Seeing as the liver is 
central to lipid homeostasis.. This is of importance since perturbations to SIRT3 result in fatty 
liver. Experiments involving an in vivo mouse model to determine if FA affects acetylation 
status of key proteins involved in hepatic fuel metabolism are warranted. Such experiments 
could include looking at the expression profiles of these proteins before and after treatment with 
FA as well as looking at the morphology of the liver to determine pathogenicity.   
Finally, seeing as FA affected mitochondrial function through SIRT3 it would be interesting to 
observe the effects of FA on the microRNA environment and how changes here can further 
manipulate SIRT3 regulation. Indeed, the microRNA miR-34a and miR-199a have been shown 
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 Appendix 1: Raw data for MTT 
 
Table 1: Raw data used to determine the IC50 value using the cell viability (MTT) assay. 
FA concentration 
(µg/ml) 
Log FA concentration Average absorbance Cell viability (%) 
0 0.00 0.9201 100.00 
25 1.40 0.8216 89.30 
50 1.70 0.8619 93.67 
100 2.00 0.4108 44.65 
250 2.40 0.1402 15.24 
350 2.54 0.1104 12.00 
































Figure 1: Caspase-3/-7 activity was significantly higher in cells stimulated with FA compared 


























Figure 1: Standard curve using known concentrations of bovine serum albumin for the 











y = 0.9501x + 0.1155 












Appendix 4: SCGE results 















Figure 1: DNA fragmentation was markedly higher in cells exposed to FA (B) than untreated 
control cells (A) (p<0.0001). 
 
